{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":76,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":76,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"583d3ed4173f","filters":{"venue":"JTO Clinical and Research Reports"}},"results":[{"id":"W4225123144","doi":"10.1016/j.jtocrr.2022.100332","title":"Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Janssen Pharmaceuticals; NIHR Leicester Clinical Research Facility; Eli Lilly Japan; Chugai Pharmaceutical; Pfizer Japan; Merck Sharp and Dohme; EMD Serono; Genentech; Daiichi-Sankyo; National Institute for Health and Care Research; Exelixis; Kissei; Bristol-Myers Squibb; Society for Academic Continuing Medical Education; Comprehensive Cancer Center, City of Hope; Merck KGaA; Boehringer Ingelheim Japan; Taiho Pharmaceutical; F. Hoffmann-La Roche; Takeda Pharmaceutical Company; Novartis Pharma; AbbVie; Bayer; Gilead Sciences; Roche; Novartis; Kyowa Hakko Kirin; Sanofi; Manchester Biomedical Research Centre; Yuhan; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Pfizer; AstraZeneca; Ignyta; Ono Pharmaceutical; Eli Lilly and Company","keywords":"ROS1; Medicine; Term (time); Oncology; Internal medicine; Cancer; Adenocarcinoma; Physics","authors":[{"name":"Alexander Drilon","is_ca":false},{"name":"Chao‐Hua Chiu","is_ca":false},{"name":"Yun Fan","is_ca":false},{"name":"Byoung Chul Cho","is_ca":false},{"name":"Shun Lü","is_ca":false},{"name":"Myung‐Ju Ahn","is_ca":false},{"name":"Matthew Krebs","is_ca":false},{"name":"Stephen V. Liu","is_ca":false},{"name":"Thomas John","is_ca":false},{"name":"Gregory A. Otterson","is_ca":false},{"name":"Daniel S.W. Tan","is_ca":false},{"name":"Tejas Patil","is_ca":false},{"name":"Rafał Dziadziuszko","is_ca":false},{"name":"Erminia Massarelli","is_ca":false},{"name":"Takashi Seto","is_ca":false},{"name":"Robert C. Doebele","is_ca":false},{"name":"Bethany Pitcher","is_ca":true},{"name":"Nino Kurtsikidze","is_ca":false},{"name":"Sebastian Heinzmann","is_ca":false},{"name":"Salvatore Siena","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07867063295629535,"gpt":0.4960975451885746,"spread":0.4174269122322793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002179282,0.00006949155,0.0002925787,0.0001233702,0.0001929036,0.00001042664,0.00002818994,0.00005200447,0.0002376451],"category_scores_gemma":[0.0008893579,0.00005016491,0.00005699382,0.0002494016,0.0002824579,0.00002989636,0.0002337798,0.000485217,9.892992e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007081778,"about_ca_system_score_gemma":0.0003262407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000253822,"about_ca_topic_score_gemma":0.00006131611,"domain_scores_codex":[0.9980512,0.0002614191,0.0005758486,0.0003465711,0.0005594965,0.0002055239],"domain_scores_gemma":[0.9985562,0.0007845552,0.00009812289,0.0002026466,0.0001642112,0.0001942583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001166596,0.0011608,0.9169242,0.00005385756,0.000102396,0.002807326,0.0005984996,0.000001825026,0.0001403982,0.00005107087,0.0004944981,0.07649854],"study_design_scores_gemma":[0.002707997,0.001201922,0.9925543,0.0001237802,0.00004730992,0.0003478071,0.0001974743,0.000009116972,0.00007668775,0.000155372,0.002528021,0.0000502131],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992036,0.001026176,0.000002655806,0.001933808,0.0001382354,0.0007283598,0.00001216302,0.000009149564,0.004113487],"genre_scores_gemma":[0.9966397,0.000845268,0.00004839249,0.00007422621,0.00007360175,0.00004776892,0.00003354796,0.000008452903,0.002229064],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07644833,"threshold_uncertainty_score":0.2602047,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3175514092","doi":"10.1016/j.jtocrr.2021.100205","title":"Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"Janssen Pharmaceuticals; Loxo Oncology; Chugai Pharmaceutical; Genentech; Free Market Institute, Texas Tech University; National Institutes of Health; Shire; Bayer Fund; Mirati Therapeutics; Clovis Oncology; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Verily Life Sciences; Les Laboratories Pierre Fabre; Merck Sharp and Dohme; Takeda Pharmaceuticals U.S.A.; AbbVie; ACEA Biosciences; Novartis; Celgene; Merck; Spectrum Pharmaceuticals; Sanofi; EMD Serono; Mesothelioma Applied Research Foundation; Heron Therapeutics; Bristol-Myers Squibb; Ono Pharmaceutical; Eli Lilly and Company; AstraZeneca; Pfizer; Boehringer Ingelheim; Amgen; Roche","keywords":"Pembrolizumab; Medicine; Brain metastasis; Internal medicine; Chemotherapy; Lung cancer; Oncology; Confidence interval; Metastasis; Adverse effect; Cancer; Immunotherapy","authors":[{"name":"Aaron S. Mansfield","is_ca":false},{"name":"Roy S. Herbst","is_ca":false},{"name":"Gilberto de Castro","is_ca":false},{"name":"Rina Hui","is_ca":false},{"name":"Nir Peled","is_ca":false},{"name":"Dong‐Wan Kim","is_ca":false},{"name":"Silvia Novello","is_ca":false},{"name":"Miyako Satouchi","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Edward B. Garon","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Andrew Robinson","is_ca":true},{"name":"Ayman Samkari","is_ca":false},{"name":"Bilal Piperdi","is_ca":false},{"name":"Victoria Ebiana","is_ca":false},{"name":"Jianxin Lin","is_ca":false},{"name":"Tony Mok","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04276317074613412,"gpt":0.4012464907436726,"spread":0.3584833199975385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002472147,0.0002372442,0.00114834,0.0003963906,0.0001015009,0.00006716058,0.00005597814,0.0001448376,0.00004666193],"category_scores_gemma":[0.0004376344,0.0001253115,0.0001482267,0.001413446,0.0008425505,0.0001018669,0.00006004687,0.0004716675,2.241656e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005356997,"about_ca_system_score_gemma":0.000550615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009730728,"about_ca_topic_score_gemma":0.001559943,"domain_scores_codex":[0.9963225,0.0004227197,0.0008840775,0.0007367835,0.001195198,0.0004387341],"domain_scores_gemma":[0.9972173,0.0007883341,0.0002811687,0.0005100145,0.0009107706,0.0002924024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03086979,0.001608516,0.9356974,0.00008571864,0.005846528,0.001744086,0.0002413518,0.000001986853,0.0001020312,0.000009075253,0.00007167624,0.0237218],"study_design_scores_gemma":[0.0165473,0.004926771,0.9755144,0.0003249765,0.0009413733,0.00009374024,0.0002551239,0.00003249603,0.0004888466,0.00002819999,0.0006617074,0.0001850243],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958009,0.0008509588,0.00003146217,0.002062477,0.00001984898,0.001009598,0.00002749614,0.00001616606,0.0001811636],"genre_scores_gemma":[0.9977393,0.0003807587,0.0006620489,0.0003649329,0.00001978196,0.00006323052,0.0001265181,0.00002833074,0.0006151093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03981699,"threshold_uncertainty_score":0.5110055,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308522396","doi":"10.1016/j.jtocrr.2022.100431","title":"Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"Merck Sharp and Dohme; EMD Serono; Astellas Pharma; Chugai Pharmaceutical; Seagen; Mirati Therapeutics; National Cancer Institute; Genomic Health; Genentech; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Celgene; Pfizer","keywords":"Pembrolizumab; Medicine; Internal medicine; KRAS; Oncology; Hazard ratio; Chemotherapy; Confidence interval; Cancer; Immunotherapy; Colorectal cancer","authors":[{"name":"Marina Chiara Garassino","is_ca":false},{"name":"Shirish M. Gadgeel","is_ca":false},{"name":"Silvia Novello","is_ca":false},{"name":"Balázs Halmos","is_ca":false},{"name":"Enriqueta Felip","is_ca":false},{"name":"Giovanna Speranza","is_ca":true},{"name":"Rina Hui","is_ca":false},{"name":"Edward B. Garon","is_ca":false},{"name":"Hidehito Horinouchi","is_ca":false},{"name":"Shunichi Sugawara","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Răzvan Cristescu","is_ca":false},{"name":"Deepti Aurora-Garg","is_ca":false},{"name":"Andrey Loboda","is_ca":false},{"name":"Jared Lunceford","is_ca":false},{"name":"Julie Kobie","is_ca":false},{"name":"Mark Ayers","is_ca":false},{"name":"Bilal Piperdi","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Luis Paz‐Ares","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1407009378247309,"gpt":0.4856435322096953,"spread":0.3449425943849644,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004630454,0.0001771558,0.0007427492,0.0001550486,0.0003611144,0.0000381142,0.00007228113,0.00006950396,0.0002835081],"category_scores_gemma":[0.001077201,0.000118663,0.0001687686,0.0003332235,0.0009498246,0.00007742822,0.00005324414,0.0005295926,4.626884e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001471505,"about_ca_system_score_gemma":0.001941724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003920273,"about_ca_topic_score_gemma":0.00009525313,"domain_scores_codex":[0.9961141,0.0003280036,0.001139381,0.0005532144,0.001469849,0.000395435],"domain_scores_gemma":[0.9948328,0.003425674,0.0004897816,0.0002732067,0.0007144323,0.0002641733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1584321,0.002289125,0.6905137,0.0003618959,0.006893228,0.001577791,0.001974362,0.00009122006,0.0002831131,0.0005465269,0.005527134,0.1315098],"study_design_scores_gemma":[0.04394719,0.01161026,0.9107717,0.00005955703,0.0002142659,0.0006177035,0.001210731,0.0003562197,0.00008333159,0.0007861821,0.03008653,0.0002562689],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897766,0.0004609211,0.0001505348,0.007275486,0.0001853426,0.001658243,0.0001633782,0.00002547465,0.0003040611],"genre_scores_gemma":[0.992723,0.0002677148,0.004355004,0.0005631046,0.0002378429,0.0003046508,0.0002046672,0.00004451741,0.001299523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.220258,"threshold_uncertainty_score":0.4838938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3211244077","doi":"10.1016/j.jtocrr.2021.100249","title":"A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Kingston Health Sciences Centre; University of Calgary","funders":"","keywords":"Atezolizumab; Medicine; Etoposide; Hazard ratio; Oncology; Internal medicine; Chemotherapy; Carboplatin; Confidence interval; Cisplatin; Cancer; Pembrolizumab; Immunotherapy","authors":[{"name":"A. Elegbede","is_ca":true},{"name":"A.J. Gibson","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Winson Y. Cheung","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"D. Gwyn Bebb","is_ca":true},{"name":"Aliyah Pabani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1270375563583288,"gpt":0.4785684825184646,"spread":0.3515309261601359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005890051,0.0001259502,0.0006400151,0.0001819464,0.00005674696,0.00001410092,0.00005444204,0.00006854755,0.0001251036],"category_scores_gemma":[0.005502391,0.00008820483,0.00004598439,0.0008605919,0.0003413439,0.0000634059,0.000154289,0.0007275033,5.919433e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001474906,"about_ca_system_score_gemma":0.01336999,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6084371,"about_ca_topic_score_gemma":0.9109167,"domain_scores_codex":[0.9941136,0.0005989898,0.0009744648,0.0005627568,0.003274708,0.0004754679],"domain_scores_gemma":[0.9954877,0.0007135337,0.000172115,0.0004779932,0.002909176,0.0002394197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00150123,0.0002769337,0.9813895,0.0001765419,0.00007795737,0.002243264,0.0001621711,0.0000327259,0.00003361739,0.00001041841,0.00106162,0.01303399],"study_design_scores_gemma":[0.006937295,0.0004258577,0.9897969,0.0005984284,0.00001783419,0.00001216207,0.0003348527,0.0005169248,0.0003317767,0.0001638336,0.0007736898,0.00009044477],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927102,0.000407229,3.467625e-7,0.001850335,0.00007058772,0.001145985,0.000006581288,0.000005260221,0.003803523],"genre_scores_gemma":[0.9975024,0.0008347522,0.0001169216,0.0001012187,0.00005728665,0.00007377245,0.00002206835,0.00001781011,0.001273757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3024796,"threshold_uncertainty_score":0.9922233,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386954645","doi":"10.1016/j.jtocrr.2023.100580","title":"Does Multidisciplinary Team Management Improve Clinical Outcomes in NSCLC? A Systematic Review With Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"GlaxoSmithKline; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Meta-analysis; Hazard ratio; Confidence interval; Internal medicine; Grading (engineering); Random effects model; Data extraction; MEDLINE","authors":[{"name":"Gilberto de Castro","is_ca":false},{"name":"Fabiano Hahn Souza","is_ca":false},{"name":"Júlia Lima","is_ca":false},{"name":"Luis Pedro Bernardi","is_ca":false},{"name":"Carlos Henrique Andrade Teixeira","is_ca":false},{"name":"Gustavo Faibischew Prado","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5955770920631436,"gpt":0.6212303727667053,"spread":0.02565328070356176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05124677,0.0006757879,0.01798666,0.0008548882,0.0001579631,0.00009902377,0.0004012951,0.0006184105,0.00006998792],"category_scores_gemma":[0.009153129,0.0002505796,0.006846501,0.002829242,0.0006521788,0.0001024385,0.001019721,0.002807192,0.00007539426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001609346,"about_ca_system_score_gemma":0.0007605069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002840131,"about_ca_topic_score_gemma":0.0003885722,"domain_scores_codex":[0.9827664,0.003100309,0.007935785,0.002097613,0.003224669,0.0008752059],"domain_scores_gemma":[0.9893202,0.005130902,0.001754212,0.002462487,0.0005361776,0.000796014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00005841934,0.0004077549,0.009622187,0.800558,0.1522512,0.01800526,0.00001015648,9.800429e-8,9.475462e-10,0.00001047168,0.001355255,0.01772122],"study_design_scores_gemma":[0.0004267351,0.0007835571,0.002014744,0.3332192,0.6148686,0.0002663239,0.0001429512,0.000007684415,6.745351e-9,0.0001192009,0.04768404,0.0004670265],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002315086,0.9883131,0.000006678137,0.0009154004,0.0002250073,0.009538785,0.00002295491,0.00007291354,0.0008820363],"genre_scores_gemma":[0.00005887943,0.9812171,0.0003681196,0.0002467018,0.0001725895,0.002590364,0.00006369354,0.00006839544,0.0152141],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4673388,"threshold_uncertainty_score":0.9999946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4321793664","doi":"10.1016/j.jtocrr.2023.100482","title":"Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of Calgary","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Performance status; Pembrolizumab; Internal medicine; Nivolumab; Emergency department; Oncology; Immunotherapy; Cancer; Nursing","authors":[{"name":"Daniel E. Meyers","is_ca":true},{"name":"Meghann Pasternak","is_ca":true},{"name":"Samantha Dolter","is_ca":true},{"name":"Heidi A.I. Grosjean","is_ca":true},{"name":"Chloe Lim","is_ca":true},{"name":"Igor Stukalin","is_ca":true},{"name":"Siddhartha Goutam","is_ca":true},{"name":"Vishal Navani","is_ca":true},{"name":"Daniel Yick Chin Heng","is_ca":true},{"name":"Winson Y. Cheung","is_ca":true},{"name":"Don Morris","is_ca":true},{"name":"Aliyah Pabani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1030508635146237,"gpt":0.4667007910321048,"spread":0.363649927517481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001800952,0.0001225211,0.000472026,0.0002192958,0.00007900366,0.00001126475,0.00002174059,0.00007339064,0.000008248023],"category_scores_gemma":[0.0002222903,0.00006411949,0.00006293181,0.000619415,0.0003169252,0.0000643398,0.00003450985,0.0002933677,3.931385e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001355376,"about_ca_system_score_gemma":0.0004816002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001060261,"about_ca_topic_score_gemma":0.0001796821,"domain_scores_codex":[0.9978284,0.000122593,0.0007000918,0.0003220414,0.0006792292,0.0003476922],"domain_scores_gemma":[0.9989073,0.0001375008,0.0001956444,0.000244478,0.0003365498,0.0001785563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009633495,0.0002513454,0.905001,0.0001438946,0.00007807264,0.0000449945,0.0002465676,0.000005027886,0.00002631837,4.091513e-7,0.00002385703,0.08454498],"study_design_scores_gemma":[0.005816806,0.01227145,0.9807138,0.0005490414,0.000006608501,0.00000402477,0.000277713,0.00001690613,0.0001322944,0.000001409028,0.0001361839,0.00007372022],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983886,0.0003482389,3.099327e-7,0.0002680906,0.00004560785,0.0007516809,0.00000820539,0.00002117561,0.0001680174],"genre_scores_gemma":[0.9978762,0.0018535,0.00001678188,0.00001570117,0.00001533938,0.00001644313,0.00008757498,0.0000162215,0.000102219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08447126,"threshold_uncertainty_score":0.2614717,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3115817852","doi":"10.1016/j.jtocrr.2020.100137","title":"Brief Report: Risk Prediction Model Versus United States Preventive Services Task Force 2020 Draft Lung Cancer Screening Eligibility Criteria—Reducing Race Disparities","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Lung cancer screening; Cohort; Lung cancer; Demography; Population; Retrospective cohort study; Ethnic group; Task force; Race (biology); Cohort study; Cancer; Gerontology; Internal medicine; Environmental health","authors":[{"name":"Mary Pasquinelli","is_ca":false},{"name":"Martin C. Tammemägi","is_ca":true},{"name":"Kevin L. Kovitz","is_ca":false},{"name":"Marianne L. Durham","is_ca":false},{"name":"Zanë Deliu","is_ca":false},{"name":"Kayleigh Rygalski","is_ca":false},{"name":"Li Liu","is_ca":false},{"name":"Matthew Koshy","is_ca":false},{"name":"Patricia W. Finn","is_ca":false},{"name":"Lawrence Feldman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0770495536566536,"gpt":0.4782571124725352,"spread":0.4012075588158816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003418188,0.0002452093,0.0006593406,0.00008310515,0.0004236698,0.0001476376,0.00008519072,0.0002001695,0.00006896393],"category_scores_gemma":[0.002305878,0.0001854897,0.0002168057,0.0004437443,0.0003903402,0.0002671143,0.0003172887,0.0008907158,0.000001028897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001910014,"about_ca_system_score_gemma":0.0004539525,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008635398,"about_ca_topic_score_gemma":0.000349661,"domain_scores_codex":[0.9953441,0.0004204831,0.001337624,0.001208049,0.001152959,0.0005367757],"domain_scores_gemma":[0.996398,0.0009067999,0.0004440614,0.0005514984,0.0009346736,0.000764998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.003002311,0.0004792649,0.9645659,0.001250016,0.0009482811,0.002580337,0.001319987,0.001948525,0.00005329393,0.00000633308,0.02009689,0.003748905],"study_design_scores_gemma":[0.005516817,0.002090198,0.3659932,0.002161677,0.001272079,0.0001911614,0.0009958162,0.6088398,0.0006220069,0.0007477207,0.01115152,0.0004180436],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812064,0.003688104,0.0004237176,0.01247435,0.000389103,0.00123081,0.0002039027,0.0001161035,0.0002675468],"genre_scores_gemma":[0.9819824,0.01467586,0.0006259106,0.0003942449,0.0007658912,0.0002639633,0.0004331275,0.0000359535,0.0008226681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6068912,"threshold_uncertainty_score":0.9979662,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091933145","doi":"10.1016/j.jtocrr.2020.100103","title":"JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Listeria monocytogenes in Food Safety","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"EMD Serono; Johnson and Johnson; Genentech; Astellas Pharma; Eisai; Daiichi-Sankyo; Pfizer; Incyte; Pharmaceuticals Bayer; Syndax Pharmaceuticals; Clovis Oncology; Bayer Fund; AstraZeneca; Canadian Asian Studies Association; Novocure; Exelixis; Takeda Pharmaceuticals U.S.A.; Spectrum Pharmaceuticals; Merck; University of Michigan; AbbVie; Roche; Novartis; Celgene; Eli Lilly and Company; Bristol-Myers Squibb; Boehringer Ingelheim; Amgen","keywords":"Chills; Medicine; Nivolumab; Internal medicine; Gastroenterology; Combination therapy; Adverse effect; Immunotherapy; Phases of clinical research; Surgery; Cancer; Chemotherapy","authors":[{"name":"Julie R. Brahmer","is_ca":false},{"name":"Melissa L. Johnson","is_ca":false},{"name":"Manuel Cobo","is_ca":false},{"name":"Santiago Viteri","is_ca":false},{"name":"J. Coves Sarto","is_ca":false},{"name":"Ammar Sukari","is_ca":false},{"name":"Mark M. Awad","is_ca":false},{"name":"Ravi Salgia","is_ca":false},{"name":"Vali A. Papadimitrakopoulou","is_ca":false},{"name":"Arun Rajan","is_ca":false},{"name":"Nibedita Bandyopadhyay","is_ca":false},{"name":"Alicia J. Allred","is_ca":false},{"name":"Mark Wade","is_ca":false},{"name":"Gary Mason","is_ca":false},{"name":"Enrique Zudaire","is_ca":false},{"name":"Roland E. Knoblauch","is_ca":false},{"name":"Nicole L. Stone","is_ca":false},{"name":"Matthew V. Lorenzi","is_ca":false},{"name":"Raffit Hassan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.312419106822627,"gpt":0.4891006084337852,"spread":0.1766815016111582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002416289,0.0003745115,0.0007210386,0.00009243185,0.0001989961,0.00009796576,0.0003415247,0.0003348706,0.000024751],"category_scores_gemma":[0.001500662,0.0002809768,0.0001717754,0.0003653263,0.0007951529,0.00002104232,0.0006915883,0.0005256865,0.0000109101],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005081389,"about_ca_system_score_gemma":0.0003800507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003685282,"about_ca_topic_score_gemma":0.0001964972,"domain_scores_codex":[0.9946873,0.0007007085,0.001609367,0.001547378,0.0008138199,0.0006414609],"domain_scores_gemma":[0.9969243,0.0002983879,0.0004168676,0.001053,0.000890045,0.0004174352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2329483,0.0032695,0.6197904,0.0001906684,0.00216243,0.002639931,0.001259132,0.0002416487,0.07764975,0.000008046905,0.006342235,0.05349794],"study_design_scores_gemma":[0.285077,0.04164071,0.3023887,0.001130284,0.0003071924,0.00007929103,0.001412009,0.001523574,0.1175968,0.0004340944,0.2442784,0.004132025],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947538,0.001835108,0.00004205627,0.001612073,0.0002941897,0.001069191,0.0001723238,0.00003467363,0.000186567],"genre_scores_gemma":[0.9958555,0.0009787652,0.0007889433,0.0008302542,0.000583266,0.00008952103,0.0006889737,0.0000666874,0.0001181241],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3174018,"threshold_uncertainty_score":0.9999642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4280525579","doi":"10.1016/j.jtocrr.2022.100340","title":"Automating Access to Real-World Evidence","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Pediatric Oncology Group; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; Open Society Institute; Roche","keywords":"Concordance; Artificial intelligence; Gold standard (test); Data extraction; Computer science; Medicine; Natural language processing; Data collection; Machine learning; MEDLINE; Internal medicine; Statistics","authors":[{"name":"Marie-Pier Gauthier","is_ca":true},{"name":"Jennifer Law","is_ca":true},{"name":"Lisa W. Le","is_ca":true},{"name":"Janice J.N. Li","is_ca":true},{"name":"Sajda Zahir","is_ca":true},{"name":"Sharon Nirmalakumar","is_ca":true},{"name":"Christopher Pettengell","is_ca":true},{"name":"Ryan Chu","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8253776973697489,"gpt":0.7123081539362991,"spread":0.1130695434334498,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01288823,0.00006775002,0.0002370975,0.0002398882,0.0006431918,0.00007885199,0.0001190654,0.00004839181,0.0006519739],"category_scores_gemma":[0.01182724,0.00005480142,0.00006572066,0.0008630005,0.0001641742,0.0001296192,0.0005445553,0.0009101776,0.00002980674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000145555,"about_ca_system_score_gemma":0.0009486408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005915111,"about_ca_topic_score_gemma":0.000506723,"domain_scores_codex":[0.9965672,0.0004637564,0.0009630801,0.0004753715,0.001149834,0.000380737],"domain_scores_gemma":[0.996272,0.00202869,0.0001191684,0.000438791,0.0005838005,0.0005575318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001263741,0.0001585221,0.7869913,0.00008746118,0.000008868562,0.0005046095,0.0003466313,0.000006823639,0.00008291299,0.00006832311,0.0354742,0.176144],"study_design_scores_gemma":[0.00003017341,0.001521334,0.9004965,0.0004259945,0.00001905242,0.0003193157,0.001121677,0.0004934876,0.0007894438,0.006270879,0.08835566,0.0001564925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9435669,0.0002074606,0.00001257166,0.05002442,0.0007209742,0.0007054411,6.51725e-7,0.00005448042,0.004707112],"genre_scores_gemma":[0.9902484,0.0004120551,0.0002741642,0.001487249,0.0007184117,0.0002043677,0.000003767204,0.00001164132,0.006639876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1759875,"threshold_uncertainty_score":0.9964966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4318954097","doi":"10.1016/j.jtocrr.2023.100469","title":"Interventions Designed to Increase the Uptake of Lung Cancer Screening: An Equity-Oriented Scoping Review","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; Canadian Partnership Against Cancer; Public Health Ontario; University of Toronto; Women's College Hospital; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Partenariat Canadien Contre Le Cancer; Women's College Hospital","keywords":"Psychological intervention; Grey literature; Scopus; MEDLINE; Medicine; Health equity; Family medicine; Health care; Gerontology; Nursing; Public health; Political science","authors":[{"name":"Ambreen Sayani","is_ca":true},{"name":"Muhanad Ahmed Ali","is_ca":true},{"name":"Pooja Dey","is_ca":true},{"name":"Ann Marie Corrado","is_ca":true},{"name":"Carolyn Ziegler","is_ca":true},{"name":"Erika Nicholson","is_ca":true},{"name":"Aïsha Lofters","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3764621298431538,"gpt":0.6200331712581714,"spread":0.2435710414150176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01064886,0.00009967339,0.0004695589,0.0001148588,0.0001962129,0.00002479508,0.00008741911,0.00006258648,0.0001880464],"category_scores_gemma":[0.004805335,0.00005619794,0.0002404281,0.0007590987,0.0002241455,0.00005546753,0.0003821035,0.0002929463,0.000005368704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000617183,"about_ca_system_score_gemma":0.0005053586,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009818088,"about_ca_topic_score_gemma":0.0004367233,"domain_scores_codex":[0.9969011,0.0003746712,0.001091696,0.000434441,0.0008613748,0.0003367193],"domain_scores_gemma":[0.9975387,0.0006330183,0.0001640758,0.000570623,0.0006084263,0.000485188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000650752,0.001906146,0.5240903,0.03184663,0.0007312002,0.002537135,0.0002635735,0.000008519361,0.0001074381,0.0003011453,0.09806778,0.3394894],"study_design_scores_gemma":[0.00232506,0.003116725,0.6743927,0.3021381,0.0008951317,0.0001296583,0.0001843943,0.000183333,0.0002810681,0.0002974581,0.01581214,0.0002442012],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9200692,0.04436789,0.00008681509,0.02902522,0.0003431909,0.004782221,0.00001763315,0.00008730505,0.001220579],"genre_scores_gemma":[0.9018828,0.09216046,0.0005410683,0.001439323,0.0004135802,0.001370723,0.00005244917,0.00003388504,0.002105701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3392452,"threshold_uncertainty_score":0.5752782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135563856","doi":"10.1016/j.jtocrr.2021.100157","title":"Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"Boehringer Ingelheim; Pfizer Canada; AbbVie; Merck; AstraZeneca; Novartis; Pfizer; Takeda Pharmaceutical Company; Bristol-Myers Squibb","keywords":"Crizotinib; Medicine; Internal medicine; Alectinib; ALK inhibitor; Anaplastic lymphoma kinase; Oncology; Ceritinib; Lung cancer; Context (archaeology); Population; Hazard ratio; Brain metastasis; Gastroenterology; Cancer; Metastasis; Confidence interval; Biology","authors":[{"name":"A.J. Gibson","is_ca":true},{"name":"Adrian Box","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"A. Elegbede","is_ca":true},{"name":"Desirée Hao","is_ca":true},{"name":"Randeep Sangha","is_ca":true},{"name":"D. Gwyn Bebb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05235902605818746,"gpt":0.4677355556769182,"spread":0.4153765296187307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001330861,0.0001852823,0.0005945061,0.0001342914,0.0003504703,0.00006708204,0.0000393064,0.0001280745,0.0001935883],"category_scores_gemma":[0.002814516,0.0001169948,0.0001698763,0.0005125534,0.0002906496,0.0001177212,0.00008765765,0.0004765619,0.000002141898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003792646,"about_ca_system_score_gemma":0.0009225096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001091847,"about_ca_topic_score_gemma":0.001582447,"domain_scores_codex":[0.996966,0.0001558565,0.0007171471,0.0007580759,0.0009373874,0.0004655144],"domain_scores_gemma":[0.9962939,0.0005344817,0.0001970984,0.0004348132,0.002105873,0.0004338317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004127546,0.0008023393,0.9658287,0.0001326237,0.0004701501,0.0003294283,0.0001598603,5.414316e-7,0.00006735256,0.0000436326,0.02130686,0.01044574],"study_design_scores_gemma":[0.003455289,0.0007013055,0.9591949,0.0005450843,0.0002520925,0.000008975235,0.00008625425,0.00001226457,0.0002613937,0.0001502011,0.03517802,0.0001542177],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9824885,0.0007977174,0.00001072889,0.008169615,0.000806403,0.001770825,0.00007809635,0.00005745519,0.005820679],"genre_scores_gemma":[0.9752013,0.001139572,0.001283311,0.0002322978,0.000545539,0.000448444,0.0001905496,0.00004790088,0.02091107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01509039,"threshold_uncertainty_score":0.4770911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225994592","doi":"10.1016/j.jtocrr.2022.100324","title":"Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Merck Sharp and Dohme; Roche; Novartis; Amgen; Pfizer; Les Laboratories Pierre Fabre; Novartis Pharmaceuticals Corporation; AstraZeneca; Takeda Pharmaceutical Company; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dabrafenib; Hazard ratio; Medicine; Trametinib; Internal medicine; Oncology; Confidence interval; Proportional hazards model; Vemurafenib; Cancer","authors":[{"name":"Bruce E. Johnson","is_ca":false},{"name":"Christina S. Baik","is_ca":false},{"name":"Julien Mazières","is_ca":false},{"name":"Harry J.M. Groen","is_ca":false},{"name":"Barbara Melosky","is_ca":true},{"name":"Jürgen Wolf","is_ca":false},{"name":"Fatemeh Asad Zadeh Vosta Kolaei","is_ca":false},{"name":"Wen-Hsing Wu","is_ca":false},{"name":"Stefanie Knoll","is_ca":false},{"name":"Meryem Ktiouet Dawson","is_ca":false},{"name":"Adam Johns","is_ca":false},{"name":"David Planchard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07276526832441786,"gpt":0.4439244341244604,"spread":0.3711591658000425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008616886,0.0002430603,0.001121363,0.0002047594,0.0001297266,0.00002343067,0.0002592222,0.000277541,0.00003465613],"category_scores_gemma":[0.0035126,0.0001698528,0.0002625145,0.0005172336,0.0008192091,0.00001193181,0.0005255151,0.001365071,6.812807e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006764654,"about_ca_system_score_gemma":0.001484405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002048865,"about_ca_topic_score_gemma":0.004069986,"domain_scores_codex":[0.992528,0.001966158,0.002544488,0.001160657,0.001230075,0.0005706723],"domain_scores_gemma":[0.996719,0.001090615,0.0005479517,0.0008009945,0.000498845,0.0003425847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2543817,0.001006917,0.7291397,0.00003284412,0.00009501312,0.0004859968,0.00005200184,0.00002824847,0.00000928672,0.00001786754,0.0001873316,0.01456308],"study_design_scores_gemma":[0.1210663,0.05444521,0.8094368,0.00007311909,0.00003414715,0.000007077561,0.000453714,0.000007600426,0.00008166847,0.00004487597,0.01403623,0.0003132636],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959848,0.0001251286,0.00000427241,0.0001438634,0.0006439267,0.001600758,0.00006332901,0.00001236796,0.001421532],"genre_scores_gemma":[0.9983872,0.0002301066,0.0004631524,0.00005431738,0.0001573742,0.0001449499,0.0002347189,0.00003642242,0.0002917981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1333154,"threshold_uncertainty_score":0.6926396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205902408","doi":"10.1016/j.jtocrr.2022.100276","title":"Performance of an RNA-Based Next-Generation Sequencing Assay for Combined Detection of Clinically Actionable Fusions and Hotspot Mutations in NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Pfizer Canada; AstraZeneca; Bayer; Novartis; Pfizer; Eli Lilly and Company","keywords":"Computational biology; DNA sequencing; RNA; Multiplex; Housekeeping gene; Biology; Gene; Bioinformatics; Genetics; Gene expression","authors":[{"name":"Patrice Desmeules","is_ca":true},{"name":"Dominique K. Boudreau","is_ca":true},{"name":"Nathalie Bastien","is_ca":true},{"name":"Marie‐Chloé Boulanger","is_ca":true},{"name":"Yohan Bossé","is_ca":true},{"name":"Philippe Joubert","is_ca":true},{"name":"Christian Couture","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1285371054467086,"gpt":0.4045420364913926,"spread":0.276004931044684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004548233,0.00005632779,0.0001574818,0.00008408954,0.0002053967,0.0000135227,0.00004718818,0.00008834028,0.000006881763],"category_scores_gemma":[0.00219412,0.00005353129,0.00005295174,0.0001273283,0.0001794651,0.000007900617,0.0000990351,0.0001823029,3.653397e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002576663,"about_ca_system_score_gemma":0.0004891405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001617091,"about_ca_topic_score_gemma":0.0002335346,"domain_scores_codex":[0.9984783,0.0002075013,0.0006796309,0.000282578,0.0002181835,0.0001337966],"domain_scores_gemma":[0.9988243,0.0003833401,0.0002009359,0.0001921664,0.0003187927,0.0000804412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008420459,0.0003755424,0.04114111,0.00006669429,0.00002100819,0.000009126575,0.00004136121,0.003678023,0.9290202,0.00002374369,0.0001162274,0.02466491],"study_design_scores_gemma":[0.006476968,0.02698275,0.161783,0.0000974175,0.00008738122,0.0001121409,0.001198271,0.3501753,0.4402605,0.001732862,0.01050771,0.000585687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988701,0.0001006777,0.0002928775,0.000155209,0.0001447293,0.0003462453,0.00002315175,0.000002234662,0.00006477859],"genre_scores_gemma":[0.9985239,0.0002797293,0.0007543291,0.00004308059,0.0001203933,0.0001022184,0.0001077952,0.000008221062,0.0000603466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4887597,"threshold_uncertainty_score":0.2626725,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4313856340","doi":"10.1016/j.jtocrr.2022.100460","title":"Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in BRAF Mutation-Positive NSCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Calgary","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Systemic therapy; Targeted therapy; Medicine; Oncology; Immune checkpoint; Mutation; Immune system; Cancer research; Internal medicine; Immunotherapy; Immunology; Biology; Cancer; Genetics; Gene","authors":[{"name":"Amanda J.W. Gibson","is_ca":true},{"name":"Aliyah Pabani","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"Guillermo Martos","is_ca":true},{"name":"Winson Y. Cheung","is_ca":true},{"name":"Vishal Navani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05075850538365254,"gpt":0.391417087290026,"spread":0.3406585819063734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003255425,0.0001200608,0.0003173011,0.0001364112,0.00006666778,0.00001930823,0.00003416424,0.0001442546,0.000002428552],"category_scores_gemma":[0.0003522952,0.00008703609,0.00006767119,0.0001779392,0.0002310046,0.000004359153,0.00008584491,0.0001325523,5.69228e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001821656,"about_ca_system_score_gemma":0.0001590178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001365438,"about_ca_topic_score_gemma":0.0002756971,"domain_scores_codex":[0.9978988,0.0006708369,0.0005384329,0.0004565033,0.0002123488,0.0002231192],"domain_scores_gemma":[0.9989293,0.0004410563,0.0001155548,0.0002257061,0.0001691714,0.0001192226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000765625,0.0002213608,0.6007861,0.0002592314,0.00008045183,0.0006922451,0.000089104,0.000005791835,0.3880602,0.00002153319,0.00001574734,0.009002562],"study_design_scores_gemma":[0.001339239,0.001762528,0.7408122,0.0002349609,0.000005174799,0.00004187636,0.00006639505,0.00005685203,0.2553997,0.0001442819,0.00005312041,0.00008364192],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983583,0.0006800384,0.00001151836,0.00007341822,0.00008468961,0.0006314796,0.00001930139,0.000009241761,0.000131985],"genre_scores_gemma":[0.9970278,0.002515379,0.00001733211,0.000006416979,0.00007613729,0.00009588905,0.0001284622,0.00001335523,0.0001192387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1400261,"threshold_uncertainty_score":0.3549229,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293565846","doi":"10.1016/j.jtocrr.2022.100400","title":"BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; Alberta Health Services; McMaster University; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"Genentech; Astellas Pharma; Regeneron Pharmaceuticals; Ipsen; BeiGene; Merck KGaA; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Adverse effect; Combination therapy; Internal medicine; Pharmacokinetics; Refractory (planetary science); Oncology; Confidence interval; Progression-free survival; Phases of clinical research; Clinical endpoint; Gastroenterology; Pharmacology; Chemotherapy; Immunotherapy; Cancer; Clinical trial","authors":[{"name":"Quincy S. Chu","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Veerle Surmont","is_ca":false},{"name":"Carla van Herpen","is_ca":false},{"name":"Anne Sibille","is_ca":false},{"name":"Ben Markman","is_ca":false},{"name":"Stephen Clarke","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Mirelis Acosta Rivera","is_ca":false},{"name":"Vladimir Andelkovic","is_ca":false},{"name":"Charles M. Rudin","is_ca":false},{"name":"Stephanie Snow","is_ca":true},{"name":"Dong‐Wan Kim","is_ca":false},{"name":"Michael Sanatani","is_ca":false},{"name":"Hongxia Lin","is_ca":false},{"name":"Kinjal Sanghavi","is_ca":false},{"name":"Sarah Tannenbaum-Dvir","is_ca":false},{"name":"Paul Basciano","is_ca":false},{"name":"Deanne Lathers","is_ca":false},{"name":"Katarzyna Urbańska","is_ca":false},{"name":"Georgia Kollia","is_ca":false},{"name":"Chunsheng He","is_ca":false},{"name":"Andrew DiPiero","is_ca":false},{"name":"Yu Liu","is_ca":false},{"name":"Neal Ready","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07985497471285384,"gpt":0.466754628081248,"spread":0.3868996533683942,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008268111,0.0002102078,0.0004308594,0.000473719,0.0003516806,0.00008906345,0.0002871446,0.0002180243,0.0001802329],"category_scores_gemma":[0.001454477,0.0001703277,0.00006432593,0.0007231348,0.0002993945,0.00002859707,0.0003846963,0.00131197,0.000002879427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008825702,"about_ca_system_score_gemma":0.0006322899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00628608,"about_ca_topic_score_gemma":0.011761,"domain_scores_codex":[0.993967,0.001671916,0.00125451,0.001244957,0.001298525,0.0005631001],"domain_scores_gemma":[0.9982005,0.0002779054,0.0002207722,0.0007701899,0.000262437,0.000268149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02470527,0.02297845,0.9060702,0.00002728444,0.00007945799,0.009177971,0.001086915,0.0002771115,0.02351966,0.00001622273,0.0005559929,0.01150548],"study_design_scores_gemma":[0.04838417,0.03522914,0.8817083,0.0001046962,0.000008059946,0.0001005702,0.002754215,0.00195281,0.002693394,0.0008152293,0.02566057,0.0005888821],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970149,0.0002109566,0.000005281637,0.0005793556,0.00007714691,0.001709501,0.00003372083,0.0000129415,0.0003561337],"genre_scores_gemma":[0.9975642,0.0003015524,0.00006827898,0.00006452186,0.0001068722,0.0002543548,0.0004478668,0.00003523862,0.001157094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02510457,"threshold_uncertainty_score":0.9502715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4288969861","doi":"10.1016/j.jtocrr.2022.100385","title":"Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Genentech; PharmaMar; Daiichi-Sankyo; G1 Therapeutics; EMD Serono; Otsuka America; Ribon Therapeutics; Takeda Oncology; Mirati Therapeutics; Bayer Fund; Abbott Laboratories; Clovis Oncology; National Center for Advancing Translational Sciences; Johnson and Johnson; Les Laboratories Pierre Fabre; Merck Sharp and Dohme; Takeda Pharmaceuticals U.S.A.; Ipsen Biopharmaceuticals; Novartis; Celgene; Unum Therapeutics; Merck KGaA; Servier; Gilead Sciences; Sanofi; Roche; Yuhan; Merck; GlaxoSmithKline; Bristol-Myers Squibb; Ignyta; Eli Lilly and Company; Canadian Asian Studies Association; AstraZeneca; Aerie Pharmaceuticals; Pfizer; Ariad Pharmaceuticals; Boehringer Ingelheim; Amgen; Regeneron Pharmaceuticals","keywords":"Crizotinib; Refractory (planetary science); Medicine; Phase (matter); Term (time); Internal medicine; Oncology; Phases of clinical research; Clinical trial; Lung cancer; Materials science; Chemistry; Physics","authors":[{"name":"Scott Gettinger","is_ca":false},{"name":"Rudolf M. Huber","is_ca":false},{"name":"Dong‐Wan Kim","is_ca":false},{"name":"Lyudmila Bazhenova","is_ca":false},{"name":"Karin Holmskov Hansen","is_ca":false},{"name":"Marcello Tiseo","is_ca":false},{"name":"Corey J. Langer","is_ca":false},{"name":"Luis G. Paz-Ares Rodríguez","is_ca":false},{"name":"Howard West","is_ca":false},{"name":"Karen L. Reckamp","is_ca":false},{"name":"Glen J. Weiss","is_ca":false},{"name":"Egbert F. Smit","is_ca":false},{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Sang‐We Kim","is_ca":false},{"name":"Myung‐Ju Ahn","is_ca":false},{"name":"Edward S. Kim","is_ca":false},{"name":"Harry J.M. Groen","is_ca":false},{"name":"Joanna Pye","is_ca":false},{"name":"Yuyin Liu","is_ca":false},{"name":"Pingkuan Zhang","is_ca":false},{"name":"Florin Vranceanu","is_ca":false},{"name":"D. Ross Camidge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2062120733192719,"gpt":0.5581480541043659,"spread":0.351935980785094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01945681,0.0001235252,0.001208835,0.0001387989,0.0002049278,0.00001497119,0.00006236815,0.00008200975,0.00009991904],"category_scores_gemma":[0.01956892,0.00006954918,0.0001968132,0.0002736317,0.001172527,0.00004940917,0.0002268377,0.0006072416,1.430269e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003681049,"about_ca_system_score_gemma":0.0006927697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002939198,"about_ca_topic_score_gemma":0.00002950601,"domain_scores_codex":[0.9940901,0.00216583,0.002229062,0.00044448,0.0008377285,0.0002327751],"domain_scores_gemma":[0.9913029,0.007097328,0.0007051457,0.000402046,0.0002622636,0.0002303133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6334086,0.01242419,0.06969211,0.0005068681,0.001029995,0.001897681,0.002081964,0.000004101434,0.002411777,0.000145535,0.002283514,0.2741137],"study_design_scores_gemma":[0.7848662,0.004274228,0.2016508,0.000578321,0.0006014607,0.0003320051,0.0002519055,0.00007210505,0.0006171382,0.0005328652,0.006085119,0.0001378177],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917271,0.002156807,0.000004102462,0.002276822,0.0001793111,0.002440092,0.0001391219,0.000006960156,0.00106965],"genre_scores_gemma":[0.9971562,0.001518046,0.00005703502,0.00006410634,0.0001018654,0.0001037129,0.00005880491,0.00001125412,0.0009289485],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2739759,"threshold_uncertainty_score":0.9886897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310859181","doi":"10.1016/j.jtocrr.2022.100444","title":"First-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Merck Sharp and Dohme; Ministère de la Santé et des Services sociaux; Merck","keywords":"Pembrolizumab; Medicine; Carboplatin; Internal medicine; Chemotherapy; Oncology; Confidence interval; Retrospective cohort study; Cancer; Immunotherapy; Cisplatin","authors":[{"name":"Stephen V. Liu","is_ca":false},{"name":"Pragya Rai","is_ca":false},{"name":"Dong Wang","is_ca":false},{"name":"Xiaohan Hu","is_ca":false},{"name":"Paul Schwarzenberger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1758482435059359,"gpt":0.5244882499617058,"spread":0.3486400064557699,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007913405,0.0002011496,0.0008178765,0.0002202562,0.000860277,0.00003224168,0.0001468219,0.0001615504,0.0008350934],"category_scores_gemma":[0.003575026,0.0001462492,0.0003824342,0.0004155849,0.0005802895,0.00008823513,0.0003271129,0.0009098215,0.000004171754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007485118,"about_ca_system_score_gemma":0.001136974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009579628,"about_ca_topic_score_gemma":0.001909757,"domain_scores_codex":[0.9958211,0.000395826,0.001234353,0.0008062474,0.00112139,0.0006211229],"domain_scores_gemma":[0.9938453,0.003994919,0.0007705407,0.0006539606,0.0003983116,0.0003369674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1608534,0.003971263,0.3868617,0.0006401595,0.001073763,0.004778934,0.000802529,0.00004111862,0.001889646,0.000164007,0.09791201,0.3410115],"study_design_scores_gemma":[0.01291504,0.005813692,0.0985128,0.00003451463,0.00005713428,0.0006236567,0.0002091744,0.0001788785,0.0001641896,0.0005407605,0.8807634,0.0001868295],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9285067,0.001968565,0.00001141893,0.05861572,0.001007984,0.002388008,0.00002306152,0.0000886047,0.007389953],"genre_scores_gemma":[0.9397422,0.006091425,0.0005229739,0.002447022,0.0004984502,0.0008040218,0.00005741763,0.00005418845,0.04978229],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7828513,"threshold_uncertainty_score":0.9143687,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3208513157","doi":"10.1016/j.jtocrr.2021.100251","title":"Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Takeda Canada; Bristol-Myers Squibb Canada; EMD Serono; Amgen; Boehringer Ingelheim; Meso Scale Diagnostics; Sanofi; Roche; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Internal medicine; Hazard ratio; Stage (stratigraphy); Adverse effect; Incidence (geometry); Chemotherapy; Oncology; Cancer; Confidence interval; Immunotherapy","authors":[{"name":"Sally C. M. Lau","is_ca":true},{"name":"Malcolm Ryan","is_ca":true},{"name":"Jessica Weiss","is_ca":true},{"name":"Aline Fusco Fares","is_ca":false},{"name":"Miguel García-Pardo","is_ca":true},{"name":"Sabine Schmid","is_ca":true},{"name":"Shelley Kuang","is_ca":true},{"name":"Deirdre Kelly","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"B. C. John Cho","is_ca":true},{"name":"A. Sun","is_ca":true},{"name":"Srinivas Raman","is_ca":true},{"name":"Andrew Hope","is_ca":true},{"name":"Meredith Giuliani","is_ca":true},{"name":"Benjamin H. Lok","is_ca":true},{"name":"Andrea Bezjak","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0722457016137158,"gpt":0.4211569068315087,"spread":0.348911205217793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002708682,0.0001418103,0.0005029877,0.00009458458,0.0001372262,0.00006884186,0.00003764871,0.0001292994,0.0001710436],"category_scores_gemma":[0.0008534254,0.00007929781,0.00004231643,0.0004729102,0.0005188463,0.0001026063,0.00007321029,0.0005723323,9.20918e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008094485,"about_ca_system_score_gemma":0.0009963036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005024871,"about_ca_topic_score_gemma":0.001086486,"domain_scores_codex":[0.9971527,0.0002436325,0.0006860493,0.0005765918,0.0009751911,0.0003657925],"domain_scores_gemma":[0.9982521,0.0004427393,0.0001499175,0.0003333836,0.0005507672,0.0002711149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01997223,0.0008863476,0.8310066,0.0001533959,0.0001332855,0.001337009,0.0001875529,8.85912e-7,0.00007688558,0.000006127575,0.0002756107,0.145964],"study_design_scores_gemma":[0.02304659,0.004411474,0.9397065,0.0006366442,0.00003464828,0.0001879064,0.0002595759,0.00007805228,0.0002256545,0.000006549565,0.0312394,0.0001669898],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996147,0.0007948557,0.00001846521,0.0009373893,0.00009140647,0.0008517486,0.000005918805,0.00001742625,0.001135829],"genre_scores_gemma":[0.9928088,0.001403367,0.0001036459,0.0001174867,0.000083007,0.0000240998,0.0000481139,0.00001916772,0.00539227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.145797,"threshold_uncertainty_score":0.3233671,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389839591","doi":"10.1016/j.jtocrr.2023.100623","title":"Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Genentech; National Institutes of Health; Mirati Therapeutics; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Damon Runyon Cancer Research Foundation; LUNGevity Foundation; Computer Modelling Group; Amgen; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; V Foundation for Cancer Research","keywords":"Profiling (computer programming); Mutant; Transformation (genetics); Cancer research; Oncology; Computational biology; Medicine; Biology; Computer science; Gene; Genetics","authors":[{"name":"Bingnan Zhang","is_ca":false},{"name":"Whitney E. Lewis","is_ca":false},{"name":"C. Allison Stewart","is_ca":false},{"name":"Benjamin B. Morris","is_ca":false},{"name":"Luisa M. Solis","is_ca":false},{"name":"Alejandra G. Serrano","is_ca":false},{"name":"Yuanxin Xi","is_ca":false},{"name":"Qi Wang","is_ca":false},{"name":"Elyse R. Lopez","is_ca":false},{"name":"Kyle Concannon","is_ca":false},{"name":"Simon Heeke","is_ca":false},{"name":"Ximing Tang","is_ca":false},{"name":"Gabriela Raso","is_ca":false},{"name":"Robert J. Cardnell","is_ca":false},{"name":"Natalie I. Vokes","is_ca":false},{"name":"George Blumenschein","is_ca":false},{"name":"Yasir Y. Elamin","is_ca":false},{"name":"Frank Fosella","is_ca":false},{"name":"Anne S. Tsao","is_ca":false},{"name":"Ferdinandos Skoulidis","is_ca":false},{"name":"Celyne Bueno Hume","is_ca":false},{"name":"Koji Sasak","is_ca":false},{"name":"Jeff Lewis","is_ca":false},{"name":"Waree Rinsurongkawong","is_ca":false},{"name":"Vadeerat Rinsurongkawong","is_ca":false},{"name":"Hai T. Tran","is_ca":false},{"name":"Jianjun Zhang","is_ca":false},{"name":"Don L. Gibbons","is_ca":false},{"name":"Ara A. Vaporciyan","is_ca":false},{"name":"Jing Wang","is_ca":false},{"name":"Keunchil Park","is_ca":false},{"name":"John V. Heymach","is_ca":false},{"name":"Lauren A. Byers","is_ca":false},{"name":"Carl M. Gay","is_ca":false},{"name":"Xiuning Le","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1404393992648889,"gpt":0.4482286477040534,"spread":0.3077892484391644,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006623702,0.0002246355,0.0008926088,0.0003237271,0.0002704303,0.00005321407,0.0001432895,0.0002828034,0.00006298594],"category_scores_gemma":[0.001966058,0.0001560773,0.0003490675,0.0005948001,0.0009856006,0.0001451325,0.0003316991,0.001217397,0.00003361524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009342936,"about_ca_system_score_gemma":0.001038724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005057165,"about_ca_topic_score_gemma":0.00003456874,"domain_scores_codex":[0.9940618,0.0003223087,0.002370684,0.0007163702,0.001768861,0.0007600188],"domain_scores_gemma":[0.9956744,0.001197275,0.0004655494,0.0007058134,0.001502558,0.0004544023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008994841,0.00228071,0.5059611,0.004974218,0.003070487,0.04556911,0.005856164,0.0001357013,0.198232,0.0001814086,0.007191608,0.2175527],"study_design_scores_gemma":[0.01005399,0.004987623,0.8477963,0.001094544,0.0005030733,0.00156705,0.005694591,0.00440617,0.06526286,0.01016524,0.04761342,0.0008550893],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903972,0.002410494,0.000145153,0.002093974,0.0005004226,0.001887195,0.00003613884,0.0001107833,0.002418686],"genre_scores_gemma":[0.9928075,0.005084452,0.0004076535,0.0001367603,0.0004787598,0.00008768442,0.00022297,0.00003754602,0.0007366739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3418353,"threshold_uncertainty_score":0.6364646,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3043913046","doi":"10.1016/j.jtocrr.2020.100078","title":"Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Actelion Pharmaceuticals; AstraZeneca","keywords":"Medicine; Pathological; Univariate analysis; Univariate; Cohort; Multivariate analysis; Radiology; Hyperplasia; Lung; Multivariate statistics; Internal medicine; Pathology","authors":[{"name":"Olga V. Sazonova","is_ca":true},{"name":"Venkata Manem","is_ca":true},{"name":"Chloé Béland","is_ca":true},{"name":"Marc-André Hamel","is_ca":true},{"name":"Yves Lacasse","is_ca":true},{"name":"Marie‐Hélène Lévesque","is_ca":true},{"name":"Michèle Orain","is_ca":true},{"name":"David Joubert","is_ca":true},{"name":"Steeve Provencher","is_ca":true},{"name":"David Simonyan","is_ca":true},{"name":"Philippe Joubert","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1388772779288449,"gpt":0.4436086075436396,"spread":0.3047313296147947,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001532777,0.0001619924,0.0005610773,0.00014051,0.0001324361,0.00004186307,0.00008667028,0.00001912111,0.00004394019],"category_scores_gemma":[0.02951864,0.0001218843,0.00006917709,0.0003318969,0.0006886858,0.0001382135,0.0004938983,0.0008289983,0.00000945945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001533195,"about_ca_system_score_gemma":0.0003157246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001747988,"about_ca_topic_score_gemma":0.000002422326,"domain_scores_codex":[0.9959981,0.0004243532,0.001124122,0.0006983488,0.001272479,0.0004825772],"domain_scores_gemma":[0.9967886,0.001388447,0.000152898,0.0003230661,0.0004371033,0.0009098931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001232847,0.001246222,0.764584,0.001959721,0.00007098135,0.1601854,0.0001663888,7.390288e-7,0.02386242,0.00005665046,0.001470312,0.04516433],"study_design_scores_gemma":[0.003660595,0.005149523,0.7302581,0.0009390872,0.0000936686,0.03868434,0.0004236331,0.0004584943,0.09659592,0.00112709,0.1221363,0.0004732925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989069,0.001031438,0.000005236413,0.008575007,0.0000966973,0.0006871718,0.000002605631,0.00004399214,0.0004888126],"genre_scores_gemma":[0.9963031,0.002281864,0.0006223756,0.0002367933,0.0002443022,0.00005133565,0.00001036409,0.00002758813,0.0002222581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1215011,"threshold_uncertainty_score":0.9786561,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388798703","doi":"10.1016/j.jtocrr.2023.100602","title":"Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec; Université du Québec à Trois-Rivières","funders":"Fonds de Recherche du Québec - Santé; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval","keywords":"Pembrolizumab; Nivolumab; Radiomics; Concordance; Medicine; Oncology; Internal medicine; Cohort; Imaging biomarker; Biomarker; Radiology; Immunotherapy; Cancer; Magnetic resonance imaging","authors":[{"name":"Sevinj Yolchuyeva","is_ca":true},{"name":"Elena Giacomazzi","is_ca":true},{"name":"Marion Tonneau","is_ca":true},{"name":"Fabien Lamaze","is_ca":false},{"name":"Michèle Orain","is_ca":false},{"name":"François Coulombe","is_ca":false},{"name":"Julie Malo","is_ca":true},{"name":"Wiam Belkaïd","is_ca":true},{"name":"Bertrand Routy","is_ca":true},{"name":"Philippe Joubert","is_ca":true},{"name":"Venkata Manem","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07396518050724483,"gpt":0.4467872464758412,"spread":0.3728220659685964,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005958839,0.0002271539,0.0006995673,0.0004019052,0.0002726597,0.00009761551,0.00006127124,0.0001030221,0.000004717738],"category_scores_gemma":[0.005122979,0.0001387904,0.00006628875,0.0005570812,0.00129312,0.00009542359,0.0001529236,0.000908062,0.000001173684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004043946,"about_ca_system_score_gemma":0.0004219484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008931589,"about_ca_topic_score_gemma":0.0002137888,"domain_scores_codex":[0.9964424,0.00037814,0.000748447,0.0008361451,0.001021644,0.000573213],"domain_scores_gemma":[0.9977918,0.0009424226,0.0001122645,0.0003035784,0.0002509081,0.0005990723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001200565,0.0008614472,0.9495331,0.000103619,0.0001395703,0.0086069,0.00009208655,0.000008917201,0.00006287565,0.000005627453,0.00007290964,0.03931235],"study_design_scores_gemma":[0.0130146,0.00111612,0.9590725,0.0002632711,0.00006034661,0.0003333586,0.0003691392,0.02494339,0.000008050064,0.00003830675,0.0006271721,0.0001537796],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947504,0.0003433799,0.00006028856,0.00297737,0.00009846879,0.001454646,0.000003677361,0.0001258094,0.0001859907],"genre_scores_gemma":[0.9984725,0.0001711634,0.0006710879,0.00007490708,0.00005834859,0.0001283142,0.00003063086,0.00002927577,0.0003637755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03915857,"threshold_uncertainty_score":0.6133054,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220684825","doi":"10.1016/j.jtocrr.2022.100316","title":"Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Durvalumab; Medicine; Toxicity; Internal medicine; Regimen; Cohort; Chemoradiotherapy; Log-rank test; Cisplatin; Proportional hazards model; Overall survival; Surgery; Chemotherapy; Cancer","authors":[{"name":"Marie-Hélène Denault","is_ca":false},{"name":"Shelley Kuang","is_ca":false},{"name":"Aria Shokoohi","is_ca":false},{"name":"Bonnie Leung","is_ca":false},{"name":"Mitchell Liu","is_ca":false},{"name":"Eric Berthelet","is_ca":false},{"name":"Janessa Laskin","is_ca":false},{"name":"Sophie Sun","is_ca":false},{"name":"Tina Zhang","is_ca":false},{"name":"Barbara Melosky","is_ca":false},{"name":"Cheryl Ho","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.145011355453734,"gpt":0.4879666751240869,"spread":0.3429553196703529,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005197947,0.0001636891,0.0008136299,0.0001527048,0.0003219382,0.00002628968,0.00008858171,0.0001223275,0.0001867887],"category_scores_gemma":[0.001147871,0.0001227701,0.0002104812,0.0005019185,0.0007900422,0.00006710205,0.00007614129,0.0005487127,3.90755e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001546825,"about_ca_system_score_gemma":0.001053008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002736394,"about_ca_topic_score_gemma":0.00004252961,"domain_scores_codex":[0.9960921,0.0002593751,0.001379983,0.0006451706,0.001240811,0.0003825935],"domain_scores_gemma":[0.9969691,0.0008319061,0.0005634406,0.0005914835,0.0008265718,0.0002175018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2819067,0.004368313,0.4069398,0.0004888891,0.001648386,0.004001714,0.0004695186,0.00003749411,0.01924692,0.00006683735,0.02529649,0.2555289],"study_design_scores_gemma":[0.067334,0.06951328,0.2457248,0.000589074,0.0004174149,0.005163119,0.00333559,0.001478706,0.01757738,0.0002413803,0.5878261,0.0007991136],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913979,0.001188605,0.0001665313,0.003079422,0.0002853994,0.00184815,0.00001773433,0.00005006572,0.001966175],"genre_scores_gemma":[0.9947248,0.0002445553,0.000858675,0.0001303358,0.0001437933,0.0002926149,0.0001323757,0.00003616537,0.00343672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5625296,"threshold_uncertainty_score":0.5006418,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386570892","doi":"10.1016/j.jtocrr.2023.100572","title":"Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"William Osler Health System; University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Chugai Pharmaceutical; Merck Sharp and Dohme; Genentech; Oryzon Genomics; BeiGene; Merck KGaA; Gilead Sciences; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Placebo; Internal medicine; Lung cancer; Quality of life (healthcare); Hazard ratio; Confidence interval; Etoposide; Oncology; Chemotherapy; Surgery; Cancer; Pathology; Immunotherapy; Nursing","authors":[{"name":"Hye Ryun Kim","is_ca":false},{"name":"Mark M. Awad","is_ca":false},{"name":"Alejandro Navarro","is_ca":false},{"name":"Maya Gottfried","is_ca":false},{"name":"Solange Peters","is_ca":false},{"name":"Tibor Csőszi","is_ca":false},{"name":"Parneet Cheema","is_ca":true},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Mirjana Wollner","is_ca":false},{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Julien Mazières","is_ca":false},{"name":"Francisco J. Orlandi","is_ca":false},{"name":"Alexander Luft","is_ca":false},{"name":"Mahmut Gümüş","is_ca":false},{"name":"Terufumi Kato","is_ca":false},{"name":"Gregory P. Kalemkerian","is_ca":false},{"name":"Yiwen Luo","is_ca":false},{"name":"Melissa L. Santorelli","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Charles M. Rudin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3304689780494397,"gpt":0.5523388797000741,"spread":0.2218699016506344,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01469671,0.0002480171,0.001486031,0.0004227995,0.0002996608,0.00003567653,0.0000917074,0.0002589514,0.00008831003],"category_scores_gemma":[0.06873883,0.0001651486,0.0001746616,0.001166204,0.0007503187,0.00008073738,0.0004472924,0.0009255249,0.00000687068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001343281,"about_ca_system_score_gemma":0.001973254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004566618,"about_ca_topic_score_gemma":0.001459821,"domain_scores_codex":[0.9923856,0.0007601757,0.003114372,0.001026534,0.001758997,0.0009543087],"domain_scores_gemma":[0.98994,0.006120223,0.0005985902,0.0007271388,0.001546755,0.001067239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1253387,0.001945813,0.7125046,0.003745403,0.001219123,0.006545985,0.005376386,0.00006545038,0.001114703,0.0001061823,0.05722301,0.08481473],"study_design_scores_gemma":[0.01976062,0.01448388,0.941608,0.001144348,0.00002307393,0.0001640862,0.001537155,0.0005479258,0.0004693606,0.001878848,0.01802275,0.0003599936],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694169,0.001563008,0.000007510103,0.02338636,0.0001789534,0.004967786,0.00003985361,0.00008143618,0.0003582553],"genre_scores_gemma":[0.9880491,0.006109734,0.0001943205,0.000725924,0.0001380365,0.0005180137,0.00004791297,0.00004573489,0.004171183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2291034,"threshold_uncertainty_score":0.9391056,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4296202942","doi":"10.1016/j.jtocrr.2022.100408","title":"A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Pemetrexed; Rash; Internal medicine; Adverse effect; Neutropenia; Febrile neutropenia; Dosing; Loading dose; Oncology; Gastroenterology; Pharmacology; Urology; Toxicity; Chemotherapy; Cisplatin","authors":[{"name":"Sarina A. Piha‐Paul","is_ca":false},{"name":"George R. Simon","is_ca":false},{"name":"Chandra P. Belani","is_ca":false},{"name":"Heman Chao","is_ca":true},{"name":"Kim Gaspar","is_ca":true},{"name":"Brenda Lee","is_ca":true},{"name":"Afshin Dowlati","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2669794915815009,"gpt":0.5310140040131872,"spread":0.2640345124316864,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00401454,0.0001311079,0.0005318563,0.0001928892,0.0001519315,0.00002777809,0.0001181564,0.00004279125,0.00009530497],"category_scores_gemma":[0.001006346,0.0000852965,0.00001843702,0.001274053,0.0002161959,0.00009661741,0.0002218701,0.0009464382,4.917082e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001605046,"about_ca_system_score_gemma":0.0004689268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002511053,"about_ca_topic_score_gemma":0.0001999427,"domain_scores_codex":[0.9963043,0.0005466293,0.001048787,0.0005458099,0.00128316,0.0002713101],"domain_scores_gemma":[0.9981243,0.0006544893,0.0002741547,0.000372856,0.0003457085,0.0002284876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04515731,0.127194,0.7945217,0.0003926442,0.0001624893,0.002287478,0.001161272,0.0001444797,0.0003180114,0.00003867394,0.0001986314,0.02842326],"study_design_scores_gemma":[0.1826577,0.06239525,0.7393346,0.0003363323,0.0001937227,0.00006963471,0.003685707,0.009379022,0.0002575027,0.0001397867,0.001175479,0.0003752121],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952567,0.00003736958,0.000008915657,0.0003756018,0.00002806556,0.003949753,0.0000175383,0.00001028161,0.0003158074],"genre_scores_gemma":[0.998534,0.0000138892,0.0002184052,0.00002322225,0.00001340354,0.0006525877,0.00009468057,0.0000158957,0.0004339353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1375004,"threshold_uncertainty_score":0.4111856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282843614","doi":"10.1016/j.jtocrr.2022.100356","title":"Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With BAP1 Germline Mutation: A Case Report","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of Alberta","funders":"","keywords":"BAP1; Mesothelioma; Germline; Peritoneal mesothelioma; Germline mutation; Medicine; Pleural cavity; Pathology; In situ; Cancer research; Mutation; Biology; Surgery; Genetics; Gene; Chemistry","authors":[{"name":"A. H. Maclean","is_ca":true},{"name":"Andrew Churg","is_ca":true},{"name":"Scott Thomas Johnson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06862817006105591,"gpt":0.4137199019763877,"spread":0.3450917319153318,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003671279,0.0001570857,0.0004338599,0.0003146158,0.0002324074,0.00003624486,0.00004142813,0.00009874889,0.0001882828],"category_scores_gemma":[0.00114578,0.0001154277,0.00007635138,0.0005335283,0.0004823778,0.0001091216,0.000250229,0.0007039019,0.000002135992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001580002,"about_ca_system_score_gemma":0.0002557505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005982594,"about_ca_topic_score_gemma":0.0009696629,"domain_scores_codex":[0.9964206,0.0004449626,0.0009696975,0.000640558,0.001138101,0.00038609],"domain_scores_gemma":[0.998646,0.0004717277,0.000173945,0.0002595078,0.00009522258,0.0003536342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007565646,0.0007067249,0.5431725,0.00003011441,0.0000353796,0.4535774,0.0001442091,0.000009733118,0.0003538862,0.000004624109,0.0001678951,0.001040916],"study_design_scores_gemma":[0.001932367,0.001138976,0.881953,0.00008094734,0.00002982526,0.1129786,0.0004368712,0.0002269467,0.00007341135,0.000302686,0.0007050491,0.0001412784],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957839,0.0004342105,5.631555e-7,0.002270703,0.00006929728,0.0005690391,0.00002005672,0.00002455448,0.0008276573],"genre_scores_gemma":[0.9974162,0.00004537946,0.00006893828,0.0002042554,0.0001152382,0.0001209284,0.0001661767,0.00002269728,0.001840192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3405988,"threshold_uncertainty_score":0.4707005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3085200587","doi":"10.1016/j.jtocrr.2020.100097","title":"Two-Year Follow-Up of a Randomized Controlled Study of Integrated Smoking Cessation in a Lung Cancer Screening Program","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Alberta; Brock University; University of Calgary","funders":"Alberta Cancer Foundation; University of Calgary; Alberta Health Services","keywords":"Smoking cessation; Medicine; Lung cancer; Randomized controlled trial; Lung cancer screening; Cancer; Oncology; Environmental health; Internal medicine; Pathology","authors":[{"name":"Alain Tremblay","is_ca":true},{"name":"Niloofar Taghizadeh","is_ca":true},{"name":"Paul MacEachern","is_ca":true},{"name":"Paul Burrowes","is_ca":true},{"name":"Andrew J. Graham","is_ca":true},{"name":"Stephen Lam","is_ca":false},{"name":"Huiming Yang","is_ca":true},{"name":"Rommy Koetzler","is_ca":true},{"name":"Martin C. Tammemägi","is_ca":true},{"name":"Kathryn L. Taylor","is_ca":false},{"name":"Eric L.R. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1484564096100268,"gpt":0.4971038265500348,"spread":0.348647416940008,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01268265,0.0001096028,0.001615321,0.0002115075,0.00004644272,0.00002264685,0.00005127655,0.0001289423,0.00006599855],"category_scores_gemma":[0.01116378,0.00006980504,0.0002451096,0.0006402787,0.0002652181,0.00006126321,0.00006925349,0.0006672775,3.958807e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003074483,"about_ca_system_score_gemma":0.0002999453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002429056,"about_ca_topic_score_gemma":0.0001389848,"domain_scores_codex":[0.9951757,0.001094549,0.001912894,0.0003713223,0.001233925,0.0002116021],"domain_scores_gemma":[0.9971495,0.001011116,0.0005243021,0.0001868953,0.0009651854,0.0001630628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0915235,0.000834424,0.8958079,0.0001184218,0.0002996635,0.0001643836,0.001176394,0.000008532345,0.0001521704,0.00001113314,0.00004473195,0.009858753],"study_design_scores_gemma":[0.5183693,0.001551484,0.4695546,0.0007385084,0.0006283927,0.000007755297,0.004612834,0.004142146,0.0002130646,0.00005307062,0.0000286109,0.0001003156],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944437,0.0001836773,0.00003386087,0.0004775405,0.0001212558,0.004398162,0.000001433957,0.00002808633,0.000312303],"genre_scores_gemma":[0.9990302,0.0001333484,0.00009175022,0.00002429617,0.00009541259,0.0005384292,0.00001215834,0.00001318887,0.00006117722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4268457,"threshold_uncertainty_score":0.9971656,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389850548","doi":"10.1016/j.jtocrr.2023.100621","title":"Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Oncology; Adjuvant; Internal medicine; Subgroup analysis; Stage (stratigraphy); Epidermal growth factor receptor; Meta-analysis; Biology; Cancer; Erlotinib","authors":[{"name":"Jie Wang","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Shun Lü","is_ca":false},{"name":"Qun Wang","is_ca":false},{"name":"Shanqing Li","is_ca":false},{"name":"Wen‐Zhao Zhong","is_ca":false},{"name":"Qiming Wang","is_ca":false},{"name":"Wěi Li","is_ca":false},{"name":"Buhai Wang","is_ca":false},{"name":"Jun Chen","is_ca":false},{"name":"Ying Cheng","is_ca":false},{"name":"Hongbing Duan","is_ca":false},{"name":"Gaofeng Li","is_ca":false},{"name":"Shan Li","is_ca":false},{"name":"Yangbo Liu","is_ca":false},{"name":"Jing Liu","is_ca":false},{"name":"Xiangning Huang","is_ca":false},{"name":"Ana Bolanos","is_ca":true},{"name":"Jie He","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04608447736501201,"gpt":0.4356944729193147,"spread":0.3896099955543027,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00178183,0.0001577159,0.0005197595,0.0006525827,0.0002064932,0.00005891383,0.00004862684,0.00007575775,0.0001723558],"category_scores_gemma":[0.0007983295,0.0001033352,0.0001360038,0.002469708,0.0002226917,0.00009589425,0.0001155667,0.0004478208,0.00004060813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001486032,"about_ca_system_score_gemma":0.0002821457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001275363,"about_ca_topic_score_gemma":0.001284075,"domain_scores_codex":[0.996648,0.0002482198,0.0008063248,0.0006967979,0.001137066,0.0004635823],"domain_scores_gemma":[0.9979722,0.0003735534,0.0001317201,0.0004106664,0.0006495258,0.0004623564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002305462,0.0004662641,0.9870516,0.00004641959,0.0006481824,0.004664165,0.0005685196,0.00005114541,0.00000656572,0.000009371164,0.0006934108,0.003488916],"study_design_scores_gemma":[0.002287881,0.002171395,0.9928375,0.0001742334,0.0002835419,0.0000168108,0.0002115733,0.0001983413,0.00001520327,0.00008259268,0.001594711,0.0001262318],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955035,0.00008659102,0.00003240484,0.001921487,0.0001168048,0.001280582,0.00007287435,0.00004477749,0.0009410064],"genre_scores_gemma":[0.9960591,0.00002765849,0.000167129,0.0002001154,0.0001067429,0.0002879805,0.0002854227,0.0000226404,0.002843174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005785907,"threshold_uncertainty_score":0.4213887,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405556325","doi":"10.1016/j.jtocrr.2024.100781","title":"Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research","year":2024,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Chonnam National University; Princess Margaret Cancer Foundation","keywords":"Lung cancer; Oncology; Medicine; Cancer; Internal medicine","authors":[{"name":"Cheol‐Kyu Park","is_ca":true},{"name":"Maryam Khalil","is_ca":true},{"name":"Nhu‐An Pham","is_ca":true},{"name":"Stephanie M. Wong","is_ca":true},{"name":"Dalam Ly","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5703970070624337,"gpt":0.6704910618664188,"spread":0.1000940548039851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.03295322,0.0004105362,0.001920368,0.0008098003,0.0005958225,0.0002232067,0.0005229489,0.0009944292,0.00003181653],"category_scores_gemma":[0.005319845,0.0002919904,0.0004983339,0.001218773,0.001846993,0.0000182334,0.002104998,0.003101434,0.000009570128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004529532,"about_ca_system_score_gemma":0.005382678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001354352,"about_ca_topic_score_gemma":0.00223893,"domain_scores_codex":[0.9894766,0.003615004,0.001874788,0.002186093,0.001225342,0.001622214],"domain_scores_gemma":[0.9939544,0.001700105,0.0002052834,0.001393119,0.002078889,0.0006682618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002423544,0.0006936927,0.0001221619,0.07132304,0.00110848,0.0005115857,0.00005019402,2.376956e-7,0.00008088382,0.000603655,0.2100117,0.715252],"study_design_scores_gemma":[0.0005341357,0.0008887601,0.00001287862,0.01014436,0.0002899322,0.0001461261,0.0000204779,0.00001128154,0.000007188229,0.003355872,0.9843182,0.000270772],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003569345,0.9891358,0.000004896029,0.001926795,0.0001387474,0.007213349,0.0002719809,0.0000158026,0.0009356913],"genre_scores_gemma":[0.0002534314,0.977686,0.00009108346,0.00005776745,0.0006047057,0.01226238,0.0003980066,0.0001156378,0.008531027],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7743065,"threshold_uncertainty_score":0.9999532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3049475230","doi":"10.1016/j.jtocrr.2020.100083","title":"Survival Outcomes of Salvage Therapy for Local and Regionally Recurrent NSCLC","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Eisai; Boehringer Ingelheim; Roche","keywords":"Medicine; Radiation therapy; Cohort; Curative treatment; Stage (stratigraphy); Retrospective cohort study; Surgery; Population; Chemotherapy; Palliative care; Radiosurgery; Internal medicine; Disease","authors":[{"name":"Sara Moore","is_ca":true},{"name":"Bonnie Leung","is_ca":false},{"name":"Jonn Wu","is_ca":true},{"name":"Cheryl Ho","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2690976024827529,"gpt":0.5162934747583426,"spread":0.2471958722755898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001948739,0.00009626694,0.0005119863,0.00003327444,0.00006229281,0.00001381531,0.00003321622,0.00009334494,0.00002240251],"category_scores_gemma":[0.001302048,0.00005622029,0.0001571523,0.00008956463,0.0004590839,0.00002520099,0.00007300171,0.0002358185,9.94533e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002192552,"about_ca_system_score_gemma":0.0002347931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005741213,"about_ca_topic_score_gemma":0.00001844798,"domain_scores_codex":[0.9980898,0.0001102629,0.0005765432,0.0004139277,0.000601656,0.0002077428],"domain_scores_gemma":[0.9978066,0.001161661,0.0001015218,0.000198198,0.0003463454,0.0003856813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0012052,0.0006225468,0.8794569,0.0001828184,0.0002639448,0.0003126024,0.00009457464,1.551203e-7,0.00001719528,0.000320581,0.01114358,0.1063799],"study_design_scores_gemma":[0.003321709,0.004538074,0.9291195,0.0001354645,0.00004966485,0.00002989805,0.00009022548,0.00006325568,0.0001556209,0.00100577,0.06140955,0.00008132098],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9360215,0.003966073,0.0001150894,0.05780302,0.0002174112,0.00113005,0.00001169849,0.00001945648,0.0007157092],"genre_scores_gemma":[0.9921093,0.006501079,0.0002405395,0.0006241166,0.0002071863,0.00007318526,0.0000113928,0.00001251204,0.0002206808],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1062985,"threshold_uncertainty_score":0.2292597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392453313","doi":"10.1016/j.jtocrr.2024.100660","title":"Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Helse Midt-Norge; Norges Teknisk-Naturvitenskapelige Universitet","keywords":"Task force; Lung cancer; Cohort; Selection (genetic algorithm); Medicine; Cancer; Cohort study; Lung cancer screening; Task (project management); Demography; Environmental health; Oncology; Family medicine; Internal medicine; Political science; Computer science; Economics; Public administration; Management; Sociology; Artificial intelligence","authors":[{"name":"Olav Toai Duc Nguyen","is_ca":false},{"name":"Ioannis Fotopoulos","is_ca":false},{"name":"Maria Markaki","is_ca":false},{"name":"Ioannis Tsamardinos","is_ca":false},{"name":"Vincenzo Lagani","is_ca":true},{"name":"Oluf Dimitri Røe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05097113252259333,"gpt":0.469072000425436,"spread":0.4181008679028426,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004657919,0.0001521253,0.0003192433,0.0001022134,0.0004224579,0.0001342539,0.00007782023,0.00007411617,0.00001917391],"category_scores_gemma":[0.0003649543,0.000069309,0.0001054096,0.0005654003,0.0001660305,0.00009912336,0.00008128622,0.0005249887,4.57654e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002213668,"about_ca_system_score_gemma":0.0004425778,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0451001,"about_ca_topic_score_gemma":0.0157125,"domain_scores_codex":[0.9974802,0.0004458347,0.000582075,0.0005449292,0.0006605767,0.0002864401],"domain_scores_gemma":[0.9966021,0.002347974,0.0001898315,0.0002652521,0.0005161834,0.00007863119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001181242,0.0002674888,0.9871759,0.0004672827,0.0008365872,0.00003827669,0.003327639,0.002562969,0.000004798492,0.00001014782,0.0003744484,0.003753191],"study_design_scores_gemma":[0.001132271,0.0004565718,0.5480716,0.000461565,0.0005595519,0.000002558535,0.001557023,0.4475406,0.00001526015,0.0001017644,0.00004740348,0.00005389443],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868255,0.004701555,0.0001961462,0.003189969,0.0001856272,0.004806397,0.00006702618,0.00001105963,0.00001675887],"genre_scores_gemma":[0.9951037,0.001616164,0.00006651817,0.00008436191,0.0002151217,0.002673604,0.00003205203,0.00001933905,0.0001891279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4449776,"threshold_uncertainty_score":0.9612586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385973055","doi":"10.1016/j.jtocrr.2023.100562","title":"Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Kingston Health Sciences Centre; William Osler Health System; Queen's University; Brampton Civic Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; EMD Serono; Genentech; Incyte; Canadian Cancer Society Research Institute; Helsinn; BeiGene; Merck KGaA; Princess Margaret Cancer Foundation; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Oncology; Toxicity; Targeted therapy; Cancer","authors":[{"name":"Sally C.M. Lau","is_ca":true},{"name":"Kirstin Perdrizet","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Danilo Giffoni M. M. Mata","is_ca":true},{"name":"Jessica Weiss","is_ca":true},{"name":"Nick Holzapfel","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Harriet Feilotter","is_ca":true},{"name":"Brandon S. Sheffield","is_ca":true},{"name":"David Hwang","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Susanna Y. Cheng","is_ca":true},{"name":"Parneet Cheema","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09678955994710657,"gpt":0.459144782226494,"spread":0.3623552222793874,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002462681,0.0001577471,0.0003809877,0.0002647553,0.0002368168,0.0001148646,0.00003159634,0.0001348418,0.00002368886],"category_scores_gemma":[0.0008368751,0.00009938568,0.00004831971,0.0005410954,0.0005571041,0.0001246507,0.00008249783,0.0004261407,0.000002164241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004283253,"about_ca_system_score_gemma":0.0003737195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006063518,"about_ca_topic_score_gemma":0.0001187966,"domain_scores_codex":[0.9975727,0.0003171908,0.0005584336,0.0005482719,0.0006185899,0.0003848187],"domain_scores_gemma":[0.9986742,0.0004799435,0.0001204913,0.0002102172,0.0002456553,0.0002695162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002431045,0.002460444,0.7601094,0.0006503581,0.00126255,0.008664532,0.01250997,0.0000077825,0.02010312,0.0002867508,0.0003678222,0.1911462],"study_design_scores_gemma":[0.01177466,0.007954359,0.9517355,0.001029347,0.0002693205,0.0003783272,0.005410857,0.0001168028,0.007766501,0.006072439,0.007042951,0.000448918],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941149,0.001465659,0.000007361238,0.00176088,0.00005431168,0.002198588,0.000004535681,0.00007749246,0.0003162681],"genre_scores_gemma":[0.9966195,0.0007493988,0.001187228,0.00005574758,0.0001127447,0.000409534,0.00004881044,0.00002403921,0.0007929801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1916261,"threshold_uncertainty_score":0.405283,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281720443","doi":"10.1016/j.jtocrr.2022.100350","title":"Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Impact; Alberta Health Services; University of Alberta; University of Calgary; Alberta Health","funders":"","keywords":"Medicine; Medical prescription; Lung cancer screening; Stage (stratigraphy); Lung cancer; Computed tomography; Health care; Cost–benefit analysis; Emergency medicine; Intensive care medicine; Radiology; Internal medicine","authors":[{"name":"Nguyễn Xuân Thành","is_ca":true},{"name":"Truong‐Minh Pham","is_ca":true},{"name":"Arianna Waye","is_ca":true},{"name":"Alain Tremblay","is_ca":true},{"name":"Huiming Yang","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"Tracy Wasylak","is_ca":true},{"name":"Randeep Sangha","is_ca":true},{"name":"Douglas A. Stewart","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06801608925398014,"gpt":0.4345918053243477,"spread":0.3665757160703675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001448865,0.0001434947,0.0005038885,0.0001549434,0.0003291596,0.00003428237,0.00008268082,0.00007132277,0.0003259678],"category_scores_gemma":[0.0005881629,0.0001149154,0.0001412451,0.0005090547,0.0001476017,0.00003755653,0.0002300169,0.000628939,1.218771e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005777045,"about_ca_system_score_gemma":0.001781853,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9000334,"about_ca_topic_score_gemma":0.829066,"domain_scores_codex":[0.9968546,0.0002138928,0.0007528265,0.0006925796,0.0009860498,0.0005000417],"domain_scores_gemma":[0.9970586,0.00172852,0.0001448502,0.0003487297,0.0002851218,0.0004341558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005471327,0.0004628595,0.9373474,0.00007466066,0.0002458035,0.00166133,0.0001218486,0.0000501782,0.00001322525,0.000008208259,0.04221598,0.01725138],"study_design_scores_gemma":[0.003330702,0.0003983777,0.9564257,0.0004123578,0.00007788368,0.0000356531,0.000208826,0.002792342,0.00008037719,0.00007162378,0.03600918,0.0001569269],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857945,0.002488352,0.000010025,0.009053263,0.0004944281,0.001787647,0.0001117794,0.00001784146,0.0002421152],"genre_scores_gemma":[0.9964498,0.0002599198,0.0002277632,0.0006018771,0.000296133,0.001412677,0.000155629,0.00002488604,0.0005712583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07096738,"threshold_uncertainty_score":0.4686112,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403411452","doi":"10.1016/j.jtocrr.2024.100737","title":"CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; Centre Technologique des Résidus Industriels; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Lung cancer; Medicine; Cancer; Immunotherapy; Cancer research; Lung; Oncology; Internal medicine","authors":[{"name":"Antoine Desîlets","is_ca":true},{"name":"Wiam Belkaïd","is_ca":true},{"name":"Olivier Salko","is_ca":true},{"name":"Julie Malo","is_ca":true},{"name":"Eleyine Zarour","is_ca":true},{"name":"Adéline Jouquan","is_ca":true},{"name":"A. A. Thibaudeau","is_ca":true},{"name":"Marc‐Antoine Nolin","is_ca":true},{"name":"J. C. A. Stagg","is_ca":true},{"name":"Marie Florescu","is_ca":true},{"name":"Mustapha Tehfé","is_ca":true},{"name":"Normand Blais","is_ca":true},{"name":"Samer Tabchi","is_ca":true},{"name":"Jean Chalaoui","is_ca":true},{"name":"Philippe Stephenson","is_ca":true},{"name":"Arielle Elkrief","is_ca":true},{"name":"Vincent Quoc‐Huy Trinh","is_ca":true},{"name":"Bertrand Routy","is_ca":true},{"name":"Moïshe Liberman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09651927422717367,"gpt":0.4826450913431923,"spread":0.3861258171160186,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003989212,0.00009429265,0.0003302078,0.0003697426,0.0000367711,0.00002623531,0.00003794894,0.0000633597,0.00005308597],"category_scores_gemma":[0.0002271095,0.0000623415,0.00003323504,0.000957153,0.0001917407,0.0001265191,0.00002623294,0.0005475801,2.29295e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001414925,"about_ca_system_score_gemma":0.0004147636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003091615,"about_ca_topic_score_gemma":0.001458409,"domain_scores_codex":[0.997718,0.0002230464,0.0008019427,0.0003868267,0.0006618511,0.0002083663],"domain_scores_gemma":[0.9990187,0.0003708404,0.0000933049,0.0002266222,0.0002374043,0.00005315369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01554735,0.004218889,0.8547332,0.0002641556,0.0001788668,0.0008608188,0.0008501554,0.000006807494,0.009167294,0.00002592669,0.000179983,0.1139665],"study_design_scores_gemma":[0.006360468,0.008733421,0.9811403,0.001220002,0.0000118705,0.00003302779,0.0004688279,0.0003393131,0.000351924,0.0001783643,0.001077852,0.00008461068],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933657,0.003536071,0.00000849452,0.001184636,0.0001633633,0.001363562,8.220676e-7,0.00001864438,0.0003587095],"genre_scores_gemma":[0.9968574,0.002386269,0.00003259351,0.00004489989,0.00004546467,0.0001880847,0.00000367593,0.00001689775,0.0004247278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1264071,"threshold_uncertainty_score":0.4673618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200545467","doi":"10.1016/j.jtocrr.2021.100259","title":"Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Ethnic group; Confidence interval; Oncology; Subgroup analysis","authors":[{"name":"Pascale Tomasini","is_ca":true},{"name":"Lisa W. Le","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Janice J.N. Li","is_ca":true},{"name":"Ronald Feld","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03152248506292136,"gpt":0.4202601434878151,"spread":0.3887376584248937,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000619162,0.0001216426,0.0004681191,0.0001141527,0.0001023828,0.00001306332,0.00001535521,0.0001132702,0.0000116111],"category_scores_gemma":[0.00106692,0.00006631089,0.00006459541,0.0003686869,0.000519609,0.00006166936,0.00004011568,0.0003022197,3.882034e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005783774,"about_ca_system_score_gemma":0.000271652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004367954,"about_ca_topic_score_gemma":0.0000951633,"domain_scores_codex":[0.9978431,0.0002801802,0.0005063474,0.0003982906,0.0007896666,0.0001824211],"domain_scores_gemma":[0.9969231,0.001198017,0.0001849549,0.0002017955,0.001271007,0.0002211455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003133552,0.002216585,0.9820524,0.0002522378,0.0004116354,0.003546723,0.000151546,0.000002449965,0.000116346,0.00004359337,0.0000992209,0.007973743],"study_design_scores_gemma":[0.005794158,0.006291351,0.9737002,0.0005934587,0.0002321405,0.00007770272,0.00007484658,0.000005380655,0.01296615,0.00006008991,0.0001334623,0.00007106121],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997484,0.000297585,0.00000549819,0.0006381484,0.00004942921,0.0007309544,0.00001463135,0.00001124979,0.0007685017],"genre_scores_gemma":[0.9986555,0.0001530555,0.0001306292,0.00003041431,0.00004301521,0.00003412333,0.0000780271,0.00001367019,0.0008615837],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0128498,"threshold_uncertainty_score":0.2704079,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388666126","doi":"10.1016/j.jtocrr.2023.100601","title":"Real-World Immunotherapy Use and Effectiveness in Advanced NSCLC With Programmed Death-Ligand 1 Greater Than or Equal to 50% and Greater Than or Equal to 90%","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Internal medicine; Cohort; Oncology; PD-L1; Immunotherapy; Clinical endpoint; Chemotherapy; Population; Cancer; Clinical trial","authors":[{"name":"Ashley Jackson","is_ca":true},{"name":"Nina Chang","is_ca":true},{"name":"Deborah Akurang","is_ca":true},{"name":"Paul Wheatley‐Price","is_ca":true},{"name":"Sara Moore","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.204960016965594,"gpt":0.4796957161427269,"spread":0.2747356991771329,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005896901,0.0003245481,0.0008461602,0.0005367524,0.0002019144,0.0002063556,0.00009294976,0.0002095839,0.00003713235],"category_scores_gemma":[0.0008550206,0.0001734272,0.00009168559,0.001152604,0.0005115056,0.0001850891,0.0002223721,0.0005386564,0.000005366856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009577323,"about_ca_system_score_gemma":0.0003486816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00234504,"about_ca_topic_score_gemma":0.004273866,"domain_scores_codex":[0.9958121,0.0005301851,0.0008680453,0.001083404,0.000834248,0.0008720584],"domain_scores_gemma":[0.996982,0.001424047,0.0001088246,0.0005701805,0.0002812668,0.0006337314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1021382,0.0002166491,0.815416,0.0002233197,0.0002401597,0.004934121,0.0007157847,7.014544e-7,0.004508834,0.000009335141,0.000286425,0.07131042],"study_design_scores_gemma":[0.006657854,0.008318732,0.969824,0.001149676,0.00003025755,0.0004161899,0.00022487,0.000009793876,0.002376237,0.0001162927,0.01056702,0.0003091088],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994607,0.0001603271,0.00003954323,0.001937306,0.0001515958,0.00290384,0.0000113297,0.00008659408,0.0001024162],"genre_scores_gemma":[0.9923015,0.001255965,0.0003410174,0.0003264199,0.0001619546,0.0005128831,0.00001640041,0.00006525266,0.005018603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.154408,"threshold_uncertainty_score":0.7072156,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404630193","doi":"10.1016/j.jtocrr.2024.100772","title":"Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors","year":2024,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Medicine; Immunology","authors":[{"name":"Abdulrahman Alghabban","is_ca":true},{"name":"Lucy Corke","is_ca":true},{"name":"Hans Katzberg","is_ca":true},{"name":"Vera Bril","is_ca":true},{"name":"Carolina Barnett‐Tapia","is_ca":true},{"name":"Warren Mason","is_ca":true},{"name":"Raed Alothman","is_ca":true},{"name":"David W. Hogg","is_ca":true},{"name":"Srikala S. Sridhar","is_ca":true},{"name":"Neesha C. Dhani","is_ca":true},{"name":"Anna Spreafico","is_ca":true},{"name":"Lawson Eng","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1319917010569843,"gpt":0.4742182047809884,"spread":0.3422265037240041,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006640318,0.000550314,0.003217227,0.0007630406,0.0001017748,0.0001126991,0.0001346742,0.0007695305,0.000082381],"category_scores_gemma":[0.001333062,0.0002805375,0.000815896,0.001265016,0.0007087401,0.00005237224,0.0003861786,0.003333071,0.0001124174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001556533,"about_ca_system_score_gemma":0.0009512835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003042602,"about_ca_topic_score_gemma":0.00003041214,"domain_scores_codex":[0.9924223,0.000621071,0.003219771,0.001338729,0.001634735,0.0007634123],"domain_scores_gemma":[0.9970558,0.0003687985,0.0004444451,0.0009622113,0.0005245532,0.0006441537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003122862,0.001187877,0.04985591,0.01622824,0.0004773726,0.01465164,0.00004774844,6.432631e-9,2.608076e-7,0.0000280777,0.002176941,0.9150336],"study_design_scores_gemma":[0.001045776,0.002410198,0.01582584,0.04097681,0.0007234553,0.000846079,0.00001375059,0.000001341109,0.000001245829,0.000189392,0.9376178,0.0003482862],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0449995,0.9502662,1.002349e-7,0.0002022593,0.0002889871,0.00249791,0.00001536027,0.00006387368,0.001665842],"genre_scores_gemma":[0.007620084,0.9856849,0.00004134606,0.00001518817,0.0004611556,0.0002043241,0.0002101619,0.0001290187,0.005633858],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9354409,"threshold_uncertainty_score":0.9999647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391919142","doi":"10.1016/j.jtocrr.2024.100647","title":"Cabozantinib Response in a Patient With NSCLC Harboring Both MET Exon 14 Skipping Mutation and Secondary RET Fusion: A Case Report","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cabozantinib; Medicine; Exon; Exon skipping; Mutation; Cancer research; Oncology; Targeted therapy; Internal medicine; Cancer; Genetics; Gene; Biology","authors":[{"name":"Jamie Feng","is_ca":true},{"name":"Elizabeth Faour","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06866051547325637,"gpt":0.4670181337328081,"spread":0.3983576182595517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00520333,0.0001303332,0.0003350651,0.0003098458,0.0001604987,0.0001109934,0.00001699398,0.0001236867,0.00004334626],"category_scores_gemma":[0.00180636,0.00008720956,0.00005831111,0.000443949,0.0002500633,0.0001569198,0.00009094142,0.0006932938,0.000001475064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009008239,"about_ca_system_score_gemma":0.001131668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006195853,"about_ca_topic_score_gemma":0.0002042556,"domain_scores_codex":[0.997204,0.0003173308,0.0008472868,0.000696664,0.0006291589,0.0003055418],"domain_scores_gemma":[0.9981371,0.0008742958,0.0001105003,0.000325667,0.000240219,0.0003122059],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.001513762,0.0001759224,0.01718039,0.0001851222,0.0001146537,0.9091564,0.001735119,0.000001468665,0.0001040831,0.00002419598,0.000463426,0.06934539],"study_design_scores_gemma":[0.003067703,0.005238123,0.2121566,0.002909462,0.0002442372,0.7179723,0.002818216,0.0004534479,0.0001651451,0.0004317245,0.05424773,0.0002952997],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930394,0.002222765,0.00002004385,0.001847658,0.0002241117,0.0008102817,0.000007087256,0.0000511303,0.001777546],"genre_scores_gemma":[0.9973616,0.0002747717,0.0007306362,0.00008503124,0.0001347294,0.0001217532,0.00002319955,0.00002387041,0.001244417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1949762,"threshold_uncertainty_score":0.3556302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391792531","doi":"10.1016/j.jtocrr.2024.100645","title":"Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; National Institutes of Health; Array BioPharma; Massachusetts General Hospital; Lunit; Amgen; Pfizer; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Alectinib; Medicine; Oncology; Crizotinib; Internal medicine; Lung cancer","authors":[{"name":"Justin M. Cheung","is_ca":false},{"name":"Jiyoon Kang","is_ca":true},{"name":"Beow Y. Yeap","is_ca":true},{"name":"Jennifer Peterson","is_ca":false},{"name":"Andrew Do","is_ca":true},{"name":"Justin F. Gainor","is_ca":false},{"name":"Subba R. Digumarthy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03893543307576351,"gpt":0.4216651979989756,"spread":0.382729764923212,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001420252,0.000168826,0.0005542823,0.0002129385,0.0001329894,0.00005601413,0.00002530586,0.0001032394,0.00001217054],"category_scores_gemma":[0.0007619037,0.0001018758,0.00005664472,0.0004351666,0.0004206764,0.00008160734,0.00005894373,0.0005963363,0.000001087848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001560059,"about_ca_system_score_gemma":0.0004859137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002698583,"about_ca_topic_score_gemma":0.00006324433,"domain_scores_codex":[0.9971502,0.0003188786,0.000800539,0.000607092,0.0007517738,0.0003714717],"domain_scores_gemma":[0.9977781,0.001165801,0.0001137612,0.0002318672,0.0003349153,0.0003756046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02651755,0.00228307,0.7863891,0.001682343,0.00186536,0.009260092,0.002569657,0.00001662591,0.00004304105,0.0004312682,0.001025437,0.1679165],"study_design_scores_gemma":[0.008083154,0.005798052,0.9815238,0.002514849,0.0003033237,0.0002271701,0.000264408,0.0001057086,0.00004239431,0.0000691829,0.0009530961,0.0001149181],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994449,0.001021623,0.000008695916,0.0006354416,0.0001621745,0.001650329,0.00004821874,0.00003705324,0.001987522],"genre_scores_gemma":[0.998805,0.0003562096,0.000156643,0.0000279463,0.00004945421,0.00003312715,0.00004801608,0.0000257664,0.0004978256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1951347,"threshold_uncertainty_score":0.4154373,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4377982006","doi":"10.1016/j.jtocrr.2023.100530","title":"Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Québec Science (Canada); McGill University Health Centre","funders":"","keywords":"ROS1; Immunohistochemistry; Adenocarcinoma; Lung cancer; Carcinogenesis; Cancer research; Fluorescence in situ hybridization; Medicine; Biology; Internal medicine; Pathology; Cancer; Oncology; Gene; Genetics","authors":[{"name":"Karl Grenier","is_ca":true},{"name":"Jean‐Baptiste Rivière","is_ca":true},{"name":"Bouchra Ouled Amar Bencheikh","is_ca":true},{"name":"Andrea Liliam Gomez Corredor","is_ca":true},{"name":"B. Shieh","is_ca":true},{"name":"Hangjun Wang","is_ca":true},{"name":"Pierre Fiset","is_ca":true},{"name":"Sophie Camilleri‐Broët","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04095527057484923,"gpt":0.4228655320139387,"spread":0.3819102614390895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002318807,0.0002024806,0.0005457954,0.0001678666,0.0002919627,0.0000536853,0.00005757635,0.0003215282,0.00003117998],"category_scores_gemma":[0.002874308,0.0001314464,0.00007140737,0.0008882518,0.0006446685,0.00009916628,0.00005933522,0.0009726389,0.000002075239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001543763,"about_ca_system_score_gemma":0.0005762222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003609606,"about_ca_topic_score_gemma":0.0001044128,"domain_scores_codex":[0.9966291,0.0003142952,0.001059931,0.0007312681,0.0007985004,0.0004669708],"domain_scores_gemma":[0.9973853,0.000970731,0.0002884931,0.0003785451,0.0005224351,0.000454451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00111454,0.0006206935,0.9838305,0.000105543,0.000259921,0.003900856,0.0003733341,0.000004069862,0.007463211,0.000001388217,0.001808714,0.0005172251],"study_design_scores_gemma":[0.006589873,0.001166033,0.9886419,0.001188679,0.0002176768,0.0002274313,0.0005230019,0.0003411765,0.0007059748,0.00008050029,0.0001373654,0.0001803515],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957019,0.001076905,0.000008530085,0.001535392,0.00004367091,0.000919448,0.00003816678,0.0001309195,0.0005450641],"genre_scores_gemma":[0.9960636,0.0002975045,0.0001171128,0.00005752192,0.00003417904,0.0001828633,0.0005131736,0.00004090788,0.00269316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006757236,"threshold_uncertainty_score":0.5360228,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283463957","doi":"10.1016/j.jtocrr.2022.100371","title":"Association Between EGFR and ALK Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbotsford Veterinary Clinic; Positive Living North; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Oncology; Palliative care; Lung cancer; Cohort","authors":[{"name":"Daegan Sit","is_ca":true},{"name":"Michelle Bale","is_ca":true},{"name":"Vincent Lapointe","is_ca":true},{"name":"Robert Olson","is_ca":true},{"name":"Fred Hsu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07884287066603579,"gpt":0.4311160863668188,"spread":0.352273215700783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01534557,0.0001224794,0.0003935892,0.0003086612,0.0001689627,0.00004281641,0.00002426222,0.00008963261,0.00009146493],"category_scores_gemma":[0.01593322,0.0001075806,0.00009126271,0.0003203303,0.0000858929,0.00008224331,0.000116655,0.0005291649,0.000001373809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003289476,"about_ca_system_score_gemma":0.0002077676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001125868,"about_ca_topic_score_gemma":0.00001881669,"domain_scores_codex":[0.9951271,0.001166456,0.0011413,0.0005667495,0.001578798,0.0004195669],"domain_scores_gemma":[0.9961596,0.002504161,0.0004729037,0.0002413159,0.0003143629,0.0003076878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001128973,0.0004909577,0.8013258,0.0001218459,0.0002017752,0.001016274,0.000342904,0.000006986709,0.000005178845,0.00002156023,0.003004527,0.1923332],"study_design_scores_gemma":[0.003032602,0.002821727,0.9654746,0.00007366397,0.0001494,0.000005681864,0.0004869857,0.001100376,0.000007686416,0.002312707,0.02441393,0.0001206533],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927867,0.0003081578,0.00009681981,0.004014958,0.0001297489,0.002218317,0.00003935915,0.00002421595,0.0003817162],"genre_scores_gemma":[0.9968351,0.000133216,0.0002415797,0.000519895,0.0001095219,0.0007593618,0.0003153657,0.00001998411,0.001065958],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1922125,"threshold_uncertainty_score":0.992356,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3181684306","doi":"10.1016/j.jtocrr.2021.100212","title":"A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Queen's University; Kingston Health Sciences Centre; London Health Sciences Centre; University of Calgary; University Health Network; Ottawa Hospital; Université Laval; Centre Hospitalier de l’Université de Montréal; Hamilton Regional Laboratory Medicine Program; Queen Elizabeth II Health Sciences Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Trillium Health Centre; AstraZeneca (Canada); McMaster University; Dalhousie University; Hamilton Health Sciences; Western University; University of Toronto","funders":"Roche; AstraZeneca Canada; AstraZeneca; Pfizer","keywords":"T790M; Concordance; Digital polymerase chain reaction; Mutation; Medicine; Resistance mutation; Polymerase chain reaction; Oncology; Internal medicine; Biology; Genetics; Gene; KRAS; Reverse transcriptase","authors":[{"name":"Shamini Selvarajah","is_ca":true},{"name":"Sophie Plante","is_ca":true},{"name":"Marsha Speevak","is_ca":true},{"name":"Andrea K. Vaags","is_ca":true},{"name":"Darren Hamelinck","is_ca":true},{"name":"Martin Butcher","is_ca":true},{"name":"M. Elizabeth McCready","is_ca":true},{"name":"Daria Grafodatskaya","is_ca":true},{"name":"Normand Blais","is_ca":true},{"name":"Danh Tran‐Thanh","is_ca":true},{"name":"Xiaoduan Weng","is_ca":true},{"name":"Rami Nassabein","is_ca":true},{"name":"Wenda Greer","is_ca":true},{"name":"Ryan N. Walton","is_ca":true},{"name":"Bernard Lo","is_ca":true},{"name":"Doug Demetrick","is_ca":true},{"name":"Stephanie Santos","is_ca":true},{"name":"Bekim Sadiković","is_ca":true},{"name":"Xiao Zhang","is_ca":true},{"name":"Tong Zhang","is_ca":true},{"name":"Tara Spence","is_ca":true},{"name":"Tracy Stockley","is_ca":true},{"name":"Harriet Feilotter","is_ca":true},{"name":"Philippe Joubert","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1708741524963086,"gpt":0.5011210858427947,"spread":0.330246933346486,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001612687,0.00006487477,0.000198136,0.00006257257,0.0003421557,0.00005529723,0.00002139328,0.00005686022,0.00003661374],"category_scores_gemma":[0.002476569,0.00004314031,0.00008974192,0.0002163859,0.0000950194,0.00006984855,0.0000241762,0.0001884731,3.830455e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009677183,"about_ca_system_score_gemma":0.001024552,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02905459,"about_ca_topic_score_gemma":0.01244024,"domain_scores_codex":[0.9983892,0.000188576,0.0005268937,0.0002998904,0.00041806,0.0001773978],"domain_scores_gemma":[0.9980266,0.0006615309,0.0001351472,0.0002302899,0.0007995882,0.0001468293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002030606,0.001500793,0.8564054,0.0001289006,0.001344473,0.00284358,0.002525195,0.00006921713,0.02367694,0.00002567535,0.00004659585,0.1112302],"study_design_scores_gemma":[0.002713748,0.001056221,0.9767379,0.0001427038,0.0009893589,0.0004397526,0.005164211,0.003931037,0.006808034,0.001194783,0.0007216794,0.0001006431],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997197,0.000414462,0.000419203,0.0005501626,0.0002087385,0.001057646,0.00001167081,0.00000838011,0.0001327586],"genre_scores_gemma":[0.9989017,0.00002268636,0.0004566802,0.00004618994,0.0002814242,0.00008256475,0.00003894398,0.00001156844,0.000158192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1203325,"threshold_uncertainty_score":0.977411,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4393204492","doi":"10.1016/j.jtocrr.2024.100669","title":"Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Sanofi Genzyme; AstraZeneca Korea; EMD Serono; Genentech; Daiichi-Sankyo; G1 Therapeutics; BeiGene; Mirati Therapeutics; AstraZeneca; Novocure; Regeneron Pharmaceuticals; Sanofi; Amgen; American Association for Cancer Research; Eli Lilly and Company; Bristol-Myers Squibb; Seagen; LUNGevity Foundation; Pfizer","keywords":"Osimertinib; Oncology; Medicine; Retrospective cohort study; Cohort; Internal medicine; Mutant; Term (time); Cancer; Epidermal growth factor receptor; Biology; Genetics; Gene; Erlotinib","authors":[{"name":"William Tompkins","is_ca":false},{"name":"Connor B. Grady","is_ca":false},{"name":"Wei‐Ting Hwang","is_ca":false},{"name":"Krishna Chandrasekhara","is_ca":false},{"name":"Caroline E. McCoach","is_ca":false},{"name":"Fangdi Sun","is_ca":false},{"name":"Geoffrey Liu","is_ca":true},{"name":"Devalben Patel","is_ca":true},{"name":"Jorgé Nieva","is_ca":false},{"name":"Amanda Herrmann","is_ca":false},{"name":"Kristen A. Marrone","is_ca":false},{"name":"Vincent K. Lam","is_ca":false},{"name":"Vamsi Velcheti","is_ca":false},{"name":"Stephen V. Liu","is_ca":false},{"name":"Gabriela Liliana Bravo Montenegro","is_ca":false},{"name":"Tejas Patil","is_ca":false},{"name":"Jared Weiss","is_ca":false},{"name":"Kelsey Leigh Miller","is_ca":false},{"name":"William Schwartzman","is_ca":false},{"name":"Jonathan E. Dowell","is_ca":false},{"name":"Khvaramze Shaverdashvili","is_ca":false},{"name":"Liza C. Villaruz","is_ca":false},{"name":"Amanda Cass","is_ca":false},{"name":"Wade T. Iams","is_ca":false},{"name":"Dara L. Aisner","is_ca":false},{"name":"Charu Aggarwal","is_ca":false},{"name":"D. Ross Camidge","is_ca":false},{"name":"Melina E. Marmarelis","is_ca":false},{"name":"Lova Sun","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1094563096629582,"gpt":0.5031910424772752,"spread":0.3937347328143169,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001843322,0.00009712295,0.0003776141,0.0001207869,0.00006730251,0.0000460365,0.00003047022,0.00005611594,0.000116508],"category_scores_gemma":[0.0005513293,0.00005298409,0.00008951641,0.000275555,0.0004503751,0.00005682743,0.00004883955,0.0003588843,0.000009171876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000038648,"about_ca_system_score_gemma":0.0006927646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001776327,"about_ca_topic_score_gemma":0.00007179462,"domain_scores_codex":[0.9979899,0.0001066542,0.0006277846,0.0003531809,0.0006886825,0.0002337814],"domain_scores_gemma":[0.9984309,0.0005447527,0.00007907847,0.0002882827,0.0003930368,0.0002639262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000284493,0.0006269795,0.8799102,0.001055627,0.0008261463,0.02504409,0.0002620016,1.441459e-7,0.0001735409,0.0002389076,0.0005387419,0.09103908],"study_design_scores_gemma":[0.0006412545,0.001657818,0.9887511,0.001056403,0.0004798061,0.001373583,0.00007715212,0.00004724607,0.0002417464,0.000318976,0.005256878,0.00009808042],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942521,0.001156525,0.00009033028,0.001530055,0.0002623698,0.0004901808,0.00001754824,0.00003231033,0.00216858],"genre_scores_gemma":[0.9950751,0.001101663,0.0002052226,0.00004025646,0.0001519631,0.00003344049,0.00003829913,0.00001910348,0.003334938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1088408,"threshold_uncertainty_score":0.2160629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387783616","doi":"10.1016/j.jtocrr.2023.100594","title":"Health Care Utilization and Costs in Lung Cancer Screening Participants—A Propensity-Matched Economic Analysis","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Alberta Health; Simon Fraser University; University of Alberta; University of Saskatchewan; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Medicine; Lung cancer; Cohort; Confidence interval; Propensity score matching; Cohort study; Health care; Cancer; Demography; Emergency medicine; Internal medicine","authors":[{"name":"Alain Tremblay","is_ca":true},{"name":"Shainur Premji","is_ca":false},{"name":"Nguyễn Xuân Thành","is_ca":true},{"name":"Huiming Yang","is_ca":true},{"name":"Paul MacEachern","is_ca":true},{"name":"Erika Penz","is_ca":true},{"name":"Sonya Cressman","is_ca":true},{"name":"Eric L.R. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3476252898537681,"gpt":0.4919756895256912,"spread":0.1443503996719231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007037411,0.0001294696,0.0009104388,0.0006071966,0.0002221876,0.0001392653,0.00008661456,0.0001582682,0.00008335176],"category_scores_gemma":[0.0008455628,0.0001312766,0.0001079487,0.0006899223,0.0002481082,0.0002663914,0.0002017528,0.000377143,0.00002510292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000290961,"about_ca_system_score_gemma":0.0002574421,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01041936,"about_ca_topic_score_gemma":0.009650995,"domain_scores_codex":[0.9969783,0.0001067744,0.001421363,0.0007540319,0.00008153653,0.0006579972],"domain_scores_gemma":[0.9986284,0.0002240103,0.000401652,0.000308593,0.00008908672,0.0003483016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003835689,0.00002228998,0.9690903,0.0000594171,0.0001230906,0.00004303088,0.0004800151,0.0002235454,2.772055e-7,0.001217789,0.001621699,0.02708018],"study_design_scores_gemma":[0.0003973087,0.00007601382,0.9722717,0.00005628074,0.00001519334,0.000002297598,0.000248402,0.01233078,0.000003049878,0.001161952,0.01327067,0.0001663405],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836351,0.01011436,0.00007579954,0.003908076,0.0002482855,0.0004758128,0.00006303099,0.00003314873,0.00144635],"genre_scores_gemma":[0.9833876,0.01559178,0.0000586789,0.0002258783,0.0001563209,0.00006839601,0.00003254406,0.00001859504,0.0004601756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02691384,"threshold_uncertainty_score":0.9961703,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200254289","doi":"10.1016/j.jtocrr.2021.100269","title":"Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Foundation Medicine; Genentech; Merck Sharp and Dohme; Eli Lilly and Company; Ono Pharmaceutical; Daiichi-Sankyo; BeiGene; TG Therapeutics; Regeneron Pharmaceuticals; Johnson and Johnson; Takeda Pharmaceutical Company; Amgen; Boehringer Ingelheim; Chugai Pharmaceutical; Roche; Novartis; Sanofi; Merck; Pfizer; G1 Therapeutics; Daiichi Sankyo Europe; Bayer; AstraZeneca; Bristol-Myers Squibb","keywords":"Lung cancer; Medicine; Clinical trial; Cancer; Disease; Pandemic; Internal medicine; Oncology; Intensive care medicine; Family medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","authors":[{"name":"Upal Roy","is_ca":false},{"name":"Anne‐Marie Baird","is_ca":false},{"name":"A. Ciupek","is_ca":false},{"name":"J. Fox","is_ca":false},{"name":"Eugene Manley","is_ca":false},{"name":"Kim Norris","is_ca":false},{"name":"Giorgio V. Scagliotti","is_ca":false},{"name":"Heather A. Wakelee","is_ca":false},{"name":"Tetsuya Mitsudomi","is_ca":false},{"name":"Russell Clark","is_ca":false},{"name":"Renee Arndt","is_ca":false},{"name":"Fred R. Hirsch","is_ca":false},{"name":"Paul A. Bunn","is_ca":false},{"name":"Matthew Smeltzer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2457151774760374,"gpt":0.6083806683625385,"spread":0.3626654908865011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006722253,0.0002297425,0.001163534,0.00004377033,0.000149711,0.0000533627,0.000119574,0.0001702575,0.0006197733],"category_scores_gemma":[0.004343461,0.0001089029,0.0007022858,0.0004994026,0.0003661668,0.00005122779,0.0002455379,0.0006763542,0.000003872157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006999785,"about_ca_system_score_gemma":0.004319658,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008069713,"about_ca_topic_score_gemma":0.00499998,"domain_scores_codex":[0.9942555,0.001344114,0.001565834,0.0008804351,0.001431661,0.0005224815],"domain_scores_gemma":[0.9945024,0.00231053,0.0003943616,0.0009023864,0.0007548955,0.001135419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002921139,0.000973253,0.7970917,0.000151163,0.0009598705,0.000836979,0.00003757791,0.0000500673,0.000006318759,0.000006084514,0.1866944,0.01027156],"study_design_scores_gemma":[0.002733193,0.0009213715,0.9843661,0.001717178,0.0007126546,0.00005948054,0.0000276757,0.00009239862,0.00001517349,0.00003895272,0.009181236,0.0001345628],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9404081,0.00572953,0.000004914471,0.05107976,0.0007805928,0.001562095,0.0002199592,0.00001752825,0.0001974762],"genre_scores_gemma":[0.9809598,0.01219438,0.00002278146,0.004508619,0.0007134197,0.0003596083,0.00001806235,0.00002569562,0.001197669],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1872745,"threshold_uncertainty_score":0.9985356,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399705963","doi":"10.1016/j.jtocrr.2024.100697","title":"Brief Report: Real-World Treatment Patterns and Clinical Outcomes for Patients With Advanced ALK-Rearranged NSCLC in British Columbia","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Cancer Research Society; Cancer Research Foundation","keywords":"Medicine; Oncology; Lung cancer; Internal medicine","authors":[{"name":"Peiyao Wang","is_ca":false},{"name":"Curtis Hughesman","is_ca":false},{"name":"Stephen Yip","is_ca":true},{"name":"William W. Lockwood","is_ca":true},{"name":"Sophie Sun","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0655007970993161,"gpt":0.487848837616346,"spread":0.4223480405170299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001956789,0.0001469673,0.0007043192,0.0001076565,0.000168937,0.0002592442,0.00003311566,0.0001457601,0.00004947897],"category_scores_gemma":[0.001263731,0.0001219581,0.00019576,0.0002453737,0.0003637711,0.0001201905,0.00005936671,0.000384172,0.000001320502],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001649675,"about_ca_system_score_gemma":0.0005968494,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03854997,"about_ca_topic_score_gemma":0.2293728,"domain_scores_codex":[0.9965703,0.0001521765,0.001281326,0.0009701801,0.0005980621,0.0004279588],"domain_scores_gemma":[0.9971964,0.001416107,0.0001359561,0.0004052786,0.000392815,0.0004534636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001743755,0.00109285,0.7919078,0.0001094852,0.0003544719,0.008063645,0.00004468005,8.925566e-8,2.118314e-7,0.000003835989,0.001712785,0.1965357],"study_design_scores_gemma":[0.004953844,0.003054743,0.9447161,0.0006802463,0.000224846,0.0002366509,0.00005573835,0.00001693526,5.177454e-7,0.000236035,0.04569308,0.0001312713],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936469,0.0003321848,0.000008345058,0.001434326,0.0003931918,0.002468807,0.0000739047,0.0000609523,0.001581353],"genre_scores_gemma":[0.979966,0.002429215,0.0005081569,0.0001043879,0.0001957535,0.0004155134,0.000214301,0.00004113823,0.01612554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1964045,"threshold_uncertainty_score":0.9678524,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399705795","doi":"10.1016/j.jtocrr.2024.100696","title":"Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Center (category theory); Tertiary care; Stage (stratigraphy); Medicine; Lung cancer; Cancer; Clinical trial; Oncology; Internal medicine; Family medicine","authors":[{"name":"Navdeep Dehar","is_ca":true},{"name":"Mahbuba Meem","is_ca":true},{"name":"Ishita Aggarwal","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true},{"name":"A. Robinson","is_ca":true},{"name":"Andrea S. Fung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2734519420320826,"gpt":0.6070180270986795,"spread":0.3335660850665969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0534175,0.0002936725,0.001850547,0.0003283133,0.0002414683,0.0001265255,0.0001204311,0.0002897941,0.0000843251],"category_scores_gemma":[0.06718991,0.0001720538,0.0006291724,0.0005715832,0.001549139,0.0001508847,0.0006962047,0.001668726,0.000009227088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005015071,"about_ca_system_score_gemma":0.001447879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006616696,"about_ca_topic_score_gemma":0.001787226,"domain_scores_codex":[0.9883577,0.002213917,0.004245819,0.001978165,0.00222557,0.0009788669],"domain_scores_gemma":[0.9837795,0.01091718,0.0004209108,0.00134914,0.002634048,0.0008992309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004531128,0.0006881769,0.9088591,0.001435148,0.0003430271,0.01280438,0.0001482223,1.678351e-7,0.000005317095,0.00001532667,0.05074304,0.02042701],"study_design_scores_gemma":[0.003893049,0.001568261,0.8371335,0.001189925,0.00008569286,0.00008419221,0.00009755193,0.00002812587,0.00002672659,0.0002016747,0.1555185,0.0001728471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830275,0.002690741,0.000008883304,0.004997737,0.0008015065,0.00548633,0.0001028093,0.00009994284,0.002784548],"genre_scores_gemma":[0.9815907,0.003372033,0.0002985513,0.000344799,0.001091429,0.0004883622,0.0002059012,0.00006828593,0.01253987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1047755,"threshold_uncertainty_score":0.9747059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7114800430","doi":"10.1016/j.jtocrr.2025.100944","title":"Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies","year":2025,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"International Association for the Study of Lung Cancer","keywords":"Targeted therapy; Lung; Cell; Cell therapy; Acquired resistance; Immunotherapy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.07505819556033028,"gpt":0.5350332632889704,"spread":0.4599750677286401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001193198,0.00007912172,0.0002596237,0.0001158449,0.000124715,0.00005760574,0.00002152659,0.00007067468,0.00001406138],"category_scores_gemma":[0.0005268549,0.00005499003,0.00002326655,0.0002862838,0.0002948637,0.00007146945,0.00005027832,0.0002546825,4.947782e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002550933,"about_ca_system_score_gemma":0.000355413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002065453,"about_ca_topic_score_gemma":0.0003751043,"domain_scores_codex":[0.9986497,0.00009985018,0.000398524,0.0003866454,0.0002488658,0.0002164606],"domain_scores_gemma":[0.9991355,0.0002897535,0.00003624153,0.0001755475,0.0001934353,0.0001695429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008944595,0.0002897027,0.8936462,0.000193186,0.0001321049,0.001335346,0.001375726,0.000002311669,0.0007650233,0.002414049,0.006671623,0.09228021],"study_design_scores_gemma":[0.001691781,0.0003450775,0.938504,0.0004580415,0.00001359707,0.00001873857,0.0009628786,0.00001870736,0.0001170714,0.00560541,0.05218913,0.00007551663],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701425,0.009904338,0.00001719774,0.00909277,0.0001026093,0.0005717272,0.000002017066,0.00001536537,0.01015144],"genre_scores_gemma":[0.9898711,0.004076525,0.0004564276,0.0004271684,0.00005651595,0.00006368293,0.00000290195,0.000005663858,0.005040019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09220469,"threshold_uncertainty_score":0.2242428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391065397","doi":"10.1016/j.jtocrr.2024.100633","title":"A Prospective Observational Study of Physical Activity Levels and Physical Fitness of People at High Risk for Lung Cancer","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Royal Melbourne Hospital; University of Melbourne; Institut National de la Santé et de la Recherche Médicale; AstraZeneca; Bristol-Myers Squibb","keywords":"Observational study; Lung cancer; Physical activity; Medicine; Physical fitness; Cancer; Prospective cohort study; Physical therapy; Oncology; Gerontology; Environmental health; Internal medicine","authors":[{"name":"Asha Bonney","is_ca":false},{"name":"Catherine L. Granger","is_ca":false},{"name":"Daniel Steinfort","is_ca":false},{"name":"Henry Marshall","is_ca":false},{"name":"Emily Stone","is_ca":false},{"name":"Annette McWilliams","is_ca":false},{"name":"Fraser Brims","is_ca":false},{"name":"Paul Fogarty","is_ca":false},{"name":"Linda Lin","is_ca":false},{"name":"Jiashi Li","is_ca":false},{"name":"Siyuan Pang","is_ca":false},{"name":"Stephen Lam","is_ca":true},{"name":"Kwun M. Fong","is_ca":false},{"name":"Renée Manser","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2351276828401595,"gpt":0.5323852277702925,"spread":0.297257544930133,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001655076,0.0001053608,0.0005760265,0.0000617784,0.00009800687,0.00001610976,0.00003525168,0.00007601312,0.00001579647],"category_scores_gemma":[0.001041653,0.00007125196,0.000145975,0.0003020957,0.0003349916,0.00007196714,0.000173657,0.0004350743,1.391129e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007311225,"about_ca_system_score_gemma":0.0003797959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003776176,"about_ca_topic_score_gemma":0.002163082,"domain_scores_codex":[0.9979353,0.0001681223,0.0003443059,0.0005155698,0.0008380472,0.0001986336],"domain_scores_gemma":[0.9968681,0.00194917,0.0001158001,0.0002271043,0.0006876605,0.0001521628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001014149,0.001720759,0.9789884,0.001019907,0.0003129043,0.00006701509,0.004411269,0.000003987037,0.0006291439,0.0001723815,0.0004226758,0.01123741],"study_design_scores_gemma":[0.000965857,0.001824408,0.9902397,0.0001958518,0.0001852031,0.0000110373,0.0004652724,0.003561878,0.001023649,0.001285601,0.0001656591,0.00007587628],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974174,0.0003466507,0.00001853749,0.0005193881,0.0002085368,0.001310785,0.000107582,0.00001535976,0.00005578444],"genre_scores_gemma":[0.9983051,0.00007543385,0.00001228497,0.000005605795,0.0005698275,0.0003014563,0.000005113763,0.00001508985,0.0007101353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01125131,"threshold_uncertainty_score":0.5708475,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214510639","doi":"10.1016/j.jtocrr.2022.100304","title":"Trends of Molecular Testing for Lung Cancer at the King Faisal Hospital, Kigali: Therapeutic and Survival Implications","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Cancer; Carboplatin; Internal medicine; Oncology; Stage (stratigraphy); Biomarker; Targeted therapy; Disease; Chemotherapy; Biology","authors":[{"name":"Achille Manirakiza","is_ca":false},{"name":"Fidel Rubagumya","is_ca":true},{"name":"Eulade Rugengamanzi","is_ca":false},{"name":"Alphonsine Mukandekezi","is_ca":false},{"name":"Jessica Beneyo","is_ca":false},{"name":"Maurice Musoni","is_ca":false},{"name":"Thierry Zawadi Muvunyi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.155052970415355,"gpt":0.5397272122547654,"spread":0.3846742418394103,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001634796,0.00006739113,0.0001976153,0.00006194656,0.0005469717,0.00001796951,0.00004180578,0.00003393359,0.00005872772],"category_scores_gemma":[0.0006139966,0.00004118307,0.00007995666,0.0002870292,0.0003653583,0.00002253945,0.0001722894,0.0002309822,5.592456e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007264202,"about_ca_system_score_gemma":0.0002820381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004140252,"about_ca_topic_score_gemma":0.00004061411,"domain_scores_codex":[0.998597,0.0001219893,0.0003832928,0.0002945647,0.000398964,0.0002041429],"domain_scores_gemma":[0.9982225,0.0009806262,0.0001252257,0.000253442,0.0003061687,0.0001120247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007165509,0.0002525822,0.9179337,0.00007280208,0.0003101322,0.00006192621,0.0002670935,0.00002272866,0.001716626,0.0005116777,0.001737513,0.07704154],"study_design_scores_gemma":[0.001486947,0.001532735,0.9623065,0.00006622642,0.0004598855,0.0001430726,0.0004455228,0.0006478346,0.0002742855,0.001530195,0.03098315,0.0001236246],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977064,0.005126579,0.00006873153,0.01508033,0.0002031391,0.000716198,0.00004410016,0.00001543358,0.001681569],"genre_scores_gemma":[0.9970586,0.0001562805,0.0001337297,0.0001379648,0.00008989256,0.0005910905,0.00002249615,0.00001407904,0.001795834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07691791,"threshold_uncertainty_score":0.4206919,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4414439969","doi":"10.1016/j.jtocrr.2025.100910","title":"Risk Factors Associated With Incidence of Lung Cancer in Never-Smokers: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; Cancer Research UK; National Institute for Health and Care Research; Entertainment Industry Foundation; American Lung Association; American Association for Cancer Research","keywords":"Lung cancer; Incidence (geometry); Risk factor; Epidemiology; Cancer; Population","authors":[{"name":"SB Naidu","is_ca":false},{"name":"Allegra Wisking","is_ca":false},{"name":"Akul Karoshi","is_ca":false},{"name":"Sarah Burdett","is_ca":false},{"name":"Peter J. Godolphin","is_ca":false},{"name":"Sanjay Popat","is_ca":false},{"name":"Sam M. Janes","is_ca":false},{"name":"Neal Navani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3500971598906501,"gpt":0.5673434307207585,"spread":0.2172462708301084,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01521254,0.000298201,0.0090934,0.0005886644,0.00006899083,0.00003028564,0.00009995369,0.0004294778,0.0001097473],"category_scores_gemma":[0.017775,0.0001426268,0.001257058,0.002345811,0.0003025109,0.00007508171,0.0001354642,0.001359223,7.627695e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001468333,"about_ca_system_score_gemma":0.001012669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001335222,"about_ca_topic_score_gemma":0.0002994528,"domain_scores_codex":[0.992631,0.00232596,0.002690114,0.0007076728,0.001374272,0.0002710309],"domain_scores_gemma":[0.9929054,0.00379545,0.001629444,0.0006809084,0.0007904274,0.0001984112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000005512323,0.0001396998,0.2340705,0.7060509,0.05796571,0.000270358,0.00002478698,1.720075e-7,3.960024e-9,0.000001336547,0.0001067975,0.001364219],"study_design_scores_gemma":[0.0001128971,0.00009449161,0.03041087,0.2012722,0.7675581,0.00001622163,0.00001621469,0.00000277014,7.34025e-8,0.000007282825,0.0003768432,0.0001319678],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002401631,0.9941652,0.00000181161,0.00009529941,0.00002712189,0.003201836,0.00005714732,0.00001142466,0.00003854359],"genre_scores_gemma":[0.008105567,0.9901811,0.000003567347,0.0000323353,0.00001070546,0.0005319183,0.00005615541,0.00001545577,0.001063203],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7095924,"threshold_uncertainty_score":0.9904987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}